Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AANAT	SNAT	ENSG00000129673	"Aralkylamine N-acetyltransferase"	Q16613	17	76453351-76470117	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Biological rhythms, Melatonin biosynthesis"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"retina: 11.0;testis: 4.7"	"Cell type enriched"	"Detected in some"	10	"Bipolar cells: 302.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;Daudi: 2.0;SCLC-21H: 3.2;U-266/70: 2.3;U-266/84: 2.7;U-698: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054321			Supported	Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	Cytosol		"HPA054321: AB_2682449"	"unprognostic (7.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.81e-7)"	"unprognostic (1.04e-1)"	"unprognostic (6.00e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.34e-2)"	0.1	0.2	0.7	1.6	0.7	1.2	0.0	0.8	1.1	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.7	0.1	0.9	0.9	0.3	0.0	0.2	1.5	2.1	1.7	0.2	0.2	0.0	0.3	0.0	2.0	0.1	0.0	11.0	0.1	0.0	0.1	1.4	0.4	0.0	1.2	1.0	0.2	4.7	2.1	0.0	0.4	0.0	0.1	0.2	0.1	1.4	0.5	2.5	0.3	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	1.7	2.0	0.3	0.0	0.3	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.2	0.0	1.0	0.2	0.3	0.0	0.1	0.6	0.8	0.2	0.1	0.1	1.1	0.0	0.0	3.2	0.2	0.0	0.1	0.8	0.3	1.5	0.3	0.0	0.0	0.9	0.1	0.0	2.3	2.7	3.6	0.6	0.2	0.4	0.7	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.7	0.7	0.8	1.1	0.9	0.9	2.1	1.7	2.0	1.2	2.1	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	302.1	0.1	0.4	0.3	0.0	0.0	0.0	12.5	0.3	0.2	0.0	0.0	0.0	7.5	0.2	0.1	0.6	1.2	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	6.7	0.6	0.1	0.0	0.3	0.0	19.4	0.3	0.1	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.4	0.0	30.2	0.0	0.0	0.0	3.1	1.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276369-99291003	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	306	"liver: 2739.1"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 200.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 8.2"									"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		38000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	7.2	1.6	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	8.9	0.3	0.5	0.1	0.5	6.6	0.3	0.0	0.0	0.7	2739.1	0.8	0.0	0.1	0.1	0.1	1.1	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.1	1.8	0.0	0.1	0.3	0.4	0.3	0.0	0.0	0.1	1.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	15.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.1	0.3	0.0	10.7	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	8.6	200.9	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304971-99352760	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1501.5;liver: 5858.7"	"Cell type enriched"	"Detected in many"	6	"Hepatocytes: 4153.7"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"ASC diff: 6574.3"									"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA		39000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	1501.5	140.2	2.2	36.4	3.4	0.1	924.6	1.9	9.0	41.0	13.5	202.2	38.5	161.4	74.8	105.8	385.0	145.1	215.3	2.0	1.9	66.7	5858.7	373.2	25.8	4.7	2.2	117.7	49.1	7.8	24.2	6.8	3.2	26.7	114.7	0.1	67.9	26.7	66.6	159.2	237.1	73.4	4.4	72.7	141.1	2.8	2.2	19.8	94.5	228.2	16.0	287.9	118.7	2.4	0.0	0.0	0.0	0.0	6574.3	956.7	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.7	0.1	1.1	0.0	0.0	0.5	1.4	0.0	0.1	0.0	1.1	0.1	0.0	26.9	3.0	0.0	216.8	0.1	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.0	0.1	3.2	0.1	0.0	0.0	0.1	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.2	0.3	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.4	1.9	9.0	2.0	1.9	4.7	2.2	3.2	4.4	2.2	2.4	29.0	0.0	3.4	0.0	8.1	22.3	0.5	0.1	6.8	0.1	1.1	2.5	12.2	110.1	2.3	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.6	0.1	0.9	14.7	0.0	115.0	0.0	0.0	0.1	633.1	11.2	0.0	1.3	0.0	96.8	4153.7	0.1	0.0	0.0	0.0	0.0	98.8	25.4	0.6	55.3	3.5	28.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	7.1	0.7	0.0	0.1	0.2	0.1	6.6	15.0	47.9	0.0	0.1	10.4	13.1	0.1	8.9	0.1	0.0	0.2
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336497-99352746	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"intestine: 598.1;liver: 2062.2;stomach 1: 570.6"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 699.4;Gastric mucus-secreting cells: 611.2;Hepatocytes: 440.6;Undifferentiated cells: 420.5"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.1;ASC TERT1: 3.6;HSkMC: 11.9;RPMI-8226: 2.1"									"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		31000000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane, Cytosol"		"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favorable (4.55e-4)"	"prognostic favorable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	22.9	0.8	0.1	29.8	0.1	0.0	19.2	0.1	0.1	4.7	0.0	329.5	598.1	5.1	7.2	5.1	5.8	51.6	5.9	0.1	0.0	19.6	2062.2	2.9	0.6	0.1	0.1	4.0	16.7	0.1	1.6	0.1	0.1	9.4	191.9	0.0	19.3	6.2	23.9	0.7	190.7	16.3	0.1	0.7	570.6	0.8	0.1	0.5	2.9	31.1	0.5	5.9	3.6	0.2	0.0	2.1	0.0	0.0	1.4	3.6	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	1.1	0.3	11.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.8	0.2	0.0	0.1	0.1	0.8	2.1	0.8	0.0	0.3	1.1	0.5	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.3	0.1	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.1	3.2	7.3	0.7	1.3	0.0	4.0	0.0	25.0	0.0	0.1	0.3	1.0	64.3	24.8	29.5	0.0	0.0	0.1	108.4	0.0	159.5	2.3	1.3	0.8	1.2	21.6	29.5	0.3	699.4	0.0	21.1	611.2	1.3	0.0	0.0	13.2	440.6	0.0	0.0	0.2	86.3	0.0	13.2	0.0	1.0	10.5	0.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	66.3	120.8	0.0	0.6	3.1	59.4	1.4	43.7	0.0	0.0	1.3	2.0	0.0	0.7	10.6	0.0	0.0	1.8	1.6	420.5	3.6
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 5151.4"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 975.2"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Hep G2: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol		NA	NA		20000000	"Cluster 34: Basophils - Unknown function"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favorable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	2.1	0.8	0.5	0.4	0.4	0.4	4.3	1.2	1.0	1.5	0.0	0.6	164.1	0.2	0.5	0.8	0.3	0.4	0.2	0.4	0.7	1.5	5151.4	0.2	0.2	0.1	0.1	0.1	0.4	0.1	0.0	0.2	0.1	0.3	0.6	0.8	2.6	0.5	0.6	0.9	22.9	0.1	0.0	0.6	0.6	1.0	0.5	0.0	0.4	2.1	0.1	0.3	3.4	0.2	0.1	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.4	22.2	0.0	1.6	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.8	0.0	0.1	0.1	0.5	0.3	0.0	0.1	0.1	1.6	0.5	0.0	0.1	0.1	0.2	1.5	0.3	0.0	0.1	0.4	0.0	0.1	0.4	0.1	0.3	0.0	0.4	0.4	0.6	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	1.2	1.0	0.4	0.7	0.1	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.5	0.2	1.8	0.0	0.0	0.0	0.8	0.0	0.0	26.9	0.7	0.6	1.1	0.0	45.5	0.1	0.6	0.0	1.0	0.0	0.3	0.0	0.0	16.1	975.2	0.0	0.0	0.0	1.1	0.0	27.0	0.0	3.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.8	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044578, HPA061919"	Approved					NA	NA		5300000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA044578: AB_2679002, HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	141.5	71.3	48.3	52.5	48.2	28.5	111.9	48.0	56.0	92.7	55.8	158.8	94.2	134.8	142.2	114.4	95.9	69.3	124.3	45.9	54.6	175.4	264.1	73.5	51.3	47.6	48.5	118.4	49.4	50.1	41.4	60.9	47.9	116.2	100.8	36.0	65.4	124.6	80.9	54.8	94.3	118.0	49.7	51.6	91.3	52.2	48.6	83.3	79.2	75.8	55.5	158.9	73.9	51.4	84.0	66.9	194.8	110.0	344.7	316.0	116.6	136.6	237.6	143.8	125.2	77.1	96.7	96.5	77.5	197.8	92.8	69.8	135.0	188.7	137.7	69.9	56.6	67.1	83.3	306.7	332.2	118.4	51.9	287.3	143.1	108.3	84.7	151.0	112.8	99.8	125.8	53.3	192.3	94.9	160.4	105.4	156.7	20.6	79.8	115.4	108.9	50.9	230.2	96.0	74.0	97.0	82.7	96.6	155.9	141.8	78.2	82.2	85.4	130.5	82.9	86.4	95.2	55.9	74.4	135.4	134.2	77.4	135.7	21.8	21.2	35.8	32.6	18.9	29.5	26.0	35.3	30.4	23.8	26.2	34.0	31.9	3.0	51.3	14.1	20.5	49.5	32.8	48.3	48.2	48.0	56.0	45.9	54.6	47.6	48.5	47.9	49.7	48.6	51.4	69.0	105.8	78.2	22.9	48.1	39.6	85.9	257.5	109.3	31.8	32.1	74.3	127.4	78.6	94.3	55.2	10.4	290.1	51.8	80.4	197.6	94.8	24.0	146.9	159.1	56.3	79.7	45.8	14.3	83.8	277.2	131.2	37.8	113.0	26.6	83.3	47.2	188.0	118.1	38.7	12.0	101.8	87.5	48.6	27.1	22.0	187.4	43.4	53.4	15.9	63.2	152.4	77.2	27.6	13.9	78.4	86.0	255.1	41.5	34.9	95.2	316.0	56.8	46.5	111.7	55.6	127.7	30.5	48.5	74.9	23.0	83.0	58.5	147.0	104.8	68.1
ADH6	ADH-5	ENSG00000172955	"Alcohol dehydrogenase 6 (class V)"	P28332	4	99202638-99219537	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 703.8"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 325.5;Proximal tubular cells: 92.4"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 46.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 44.7"	"Not detected"	"Not detected"							"HPA067946, HPA069081"	Enhanced					NA	NA		3400000		"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA067946: AB_2732776, HPA069081: AB_2732127"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.11e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.67e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.86e-3)"	0.2	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	8.2	41.5	0.3	0.0	0.3	9.2	7.7	0.0	0.0	0.0	52.3	703.8	0.2	0.2	0.1	0.2	0.0	0.3	0.0	0.0	0.2	0.1	0.1	8.6	0.0	0.0	0.1	0.0	1.8	22.6	0.3	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	44.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	9.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.7	0.5	0.1	0.5	0.0	0.0	0.0	0.0	0.3	15.7	1.1	5.5	0.0	0.0	0.0	7.8	7.9	0.3	0.0	11.2	0.3	0.4	12.1	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.0	7.1	325.5	0.0	0.0	0.1	8.9	8.2	5.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.2	0.0	0.0	0.0	31.1	92.4	15.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	12.7	0.1
ADH7	ADH-4	ENSG00000196344	"Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide"	P40394	4	99412261-99435737	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 196.3"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 89.0;Club cells: 64.1;Squamous epithelial cells: 209.1"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC TERT1: 1.0;HaCaT: 1.2"	"Not detected"	"Not detected"							HPA039695	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane, Cytosol"		"HPA039695: AB_10795681"		"unprognostic (1.02e-2)"			"unprognostic (8.64e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.66e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.66e-1)"					"unprognostic (2.02e-1)"			"unprognostic (1.88e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	196.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	27.3	0.0	0.0	0.2	0.0	0.0	38.1	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	89.0	21.1	0.0	0.0	0.0	0.2	0.0	64.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	7.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	18.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.6	0.0	0.0	26.2	0.0	0.0	0.0	2.3	0.0	0.0	209.1	0.0	0.0	0.0	0.0	0.0	1.0
ADHFE1	FLJ32430	ENSG00000147576	"Alcohol dehydrogenase iron containing 1"	Q8IWW8	8	66432492-66468907	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 31.2;skeletal muscle: 29.2;tongue: 31.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 76.4;Cardiomyocytes: 41.6;Syncytiotrophoblasts: 116.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.2;RPTEC TERT1: 1.5"					"Low region specificity"	"Detected in all"			HPA023062	Enhanced		Approved	Vesicles		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA023062: AB_1844611"	"prognostic favorable (5.76e-5)"	"unprognostic (8.69e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (9.90e-5)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.43e-2)"	"prognostic favorable (4.55e-5)"	"unprognostic (1.37e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.66e-2)"	"unprognostic (5.94e-3)"	7.0	2.3	8.7	0.3	8.5	0.0	3.9	7.2	11.7	2.3	10.4	3.9	0.6	2.0	1.3	1.3	5.6	0.7	24.5	8.2	8.2	6.6	31.2	2.1	0.3	8.3	8.5	5.1	9.4	5.0	2.6	1.1	8.1	5.2	0.7	1.5	2.3	1.5	29.2	1.1	2.5	0.2	7.8	1.8	11.0	1.7	8.7	0.3	2.7	31.3	0.3	4.4	1.8	8.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.2	0.0	0.5	0.1	0.0	0.3	0.0	0.4	0.1	0.3	0.0	0.7	0.0	0.0	0.0	0.0	8.7	8.5	7.2	11.7	8.2	8.2	8.3	8.5	8.1	7.8	8.7	8.5	1.5	9.6	20.1	76.4	1.8	1.0	4.1	2.7	3.4	1.7	4.6	4.6	41.6	14.3	9.6	9.2	10.4	8.8	6.5	1.0	11.7	1.5	0.5	2.5	1.6	3.3	3.6	2.5	8.3	0.6	0.9	5.3	8.6	2.5	8.8	6.1	6.1	27.1	2.5	0.0	13.2	2.0	4.1	2.1	2.8	1.6	23.9	2.1	0.0	14.0	2.0	7.6	6.2	21.6	19.2	0.9	5.8	27.1	3.0	3.5	4.1	14.8	14.3	8.5	0.0	7.8	5.2	0.5	0.6	1.9	1.0	116.4	10.0	2.5	2.4	2.5
ALDH1B1	"ALDH5, ALDHX"	ENSG00000137124	"Aldehyde dehydrogenase 1 family member B1"	P30837	9	38392702-38398661	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 172.7;smooth muscle: 128.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 85.8;Ductal cells: 64.1;Hepatocytes: 128.1;Proximal tubular cells: 165.0;Theca cells: 91.7;Undifferentiated cells: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 183.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021037, HPA077080"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA		500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Cytosol"	"HPA021037: AB_1844724, HPA077080: "	"unprognostic (4.16e-1)"	"unprognostic (1.98e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.84e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (2.89e-2)"	21.2	10.4	3.2	31.4	3.2	2.9	8.9	4.1	4.0	8.5	6.4	61.5	22.9	57.7	5.7	32.7	34.9	29.0	14.7	2.7	4.8	59.2	172.7	7.3	5.1	3.5	3.3	12.6	11.3	8.5	2.5	5.2	4.3	36.9	35.5	1.5	11.1	54.5	55.8	6.3	24.8	128.0	3.4	7.2	28.2	8.3	4.0	5.1	15.4	35.9	5.6	85.1	10.5	4.1	72.2	65.5	19.8	31.8	27.6	32.5	15.8	33.6	16.9	27.8	28.3	44.2	13.7	45.2	19.7	47.4	42.0	10.0	66.0	71.4	27.4	50.8	28.5	22.4	44.7	132.2	20.0	36.0	24.0	39.0	15.3	22.6	19.5	56.6	26.8	10.6	65.6	42.8	42.8	27.3	0.1	14.4	59.1	183.3	29.0	14.9	119.9	34.5	25.1	31.7	43.3	19.9	25.7	16.7	19.4	20.6	15.9	27.9	18.2	31.9	52.4	26.9	42.5	6.5	13.2	17.8	16.4	36.0	22.1	0.3	4.2	0.2	6.7	9.2	9.6	5.5	6.5	6.1	9.5	2.6	5.1	6.2	1.0	8.0	11.9	1.2	5.0	5.3	3.2	3.2	4.1	4.0	2.7	4.8	3.5	3.3	4.3	3.4	4.0	4.1	3.3	9.6	1.7	0.0	3.7	1.0	5.7	9.4	2.2	1.2	3.7	4.2	6.6	85.8	3.8	16.5	2.1	2.0	1.2	12.8	17.6	64.1	0.6	2.3	6.4	4.7	15.6	12.8	0.5	6.9	46.6	6.6	8.2	3.4	8.9	12.8	8.9	128.1	7.2	0.0	1.1	25.5	6.1	4.1	2.4	2.2	6.5	4.2	0.0	0.0	5.5	2.1	0.0	0.5	0.5	15.0	7.7	6.8	3.7	6.1	10.3	165.0	0.3	0.7	0.0	6.0	16.1	0.6	0.8	2.1	1.0	1.8	3.3	91.7	71.7	2.8
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family member"	P05091	12	111766887-111817532	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 857.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 857.0;monocytes: 940.8;Proximal tubular cells: 882.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 212.0;myeloid DC: 213.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 213.2;monocytes: 212.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 86.8;HHSteC: 97.0;OE19: 152.2;SK-BR-3: 201.0;THP-1: 92.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051065	Approved					NA	NA		2200000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA051065: AB_2681332"	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favorable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favorable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavorable (7.71e-4)"	303.8	102.4	139.7	39.8	146.1	29.2	77.2	136.5	163.5	25.0	123.3	73.3	73.7	30.1	21.3	73.6	32.3	37.4	111.3	132.2	139.7	177.7	857.7	111.6	18.7	140.7	144.9	42.0	23.3	2.6	23.3	7.0	141.1	34.6	72.3	29.2	32.4	29.5	130.8	127.9	74.8	30.2	143.0	20.6	101.5	13.0	151.8	27.1	30.8	165.7	52.9	50.0	29.0	144.5	8.8	13.1	18.7	31.9	86.8	13.0	60.9	9.3	16.8	4.3	3.1	23.5	12.1	0.5	45.3	20.8	11.9	16.2	0.1	4.6	2.7	0.6	6.1	0.7	8.4	64.7	97.0	0.9	0.9	23.9	22.6	14.8	0.3	17.7	26.9	0.9	17.9	3.0	4.1	0.5	1.0	23.4	24.8	152.2	2.1	0.6	0.4	1.9	31.4	0.6	7.5	23.1	22.8	201.0	0.2	33.7	20.3	92.1	1.1	0.4	16.5	0.6	0.4	5.5	3.0	25.7	22.0	0.8	0.4	6.5	212.0	51.1	0.7	93.0	0.9	6.2	0.3	0.7	213.2	5.2	0.7	0.5	10.7	3.4	25.4	70.6	0.5	123.5	139.7	146.1	136.5	163.5	132.2	139.7	140.7	144.9	141.1	143.0	151.8	144.5	27.7	147.4	242.7	51.2	22.6	60.0	205.2	311.1	80.8	78.7	35.0	23.7	378.9	165.8	243.1	66.2	18.8	62.4	48.6	260.3	399.2	127.5	4.3	27.8	24.5	66.2	55.2	42.1	11.7	218.0	127.5	103.1	200.3	47.7	30.9	29.0	139.6	857.0	129.2	35.3	18.2	231.0	101.7	278.5	124.1	10.6	79.9	189.3	35.6	26.2	940.8	130.2	8.2	14.1	6.8	130.2	366.5	149.0	12.5	84.4	384.3	882.0	89.4	42.6	46.0	46.0	67.6	3.0	3.9	105.1	124.7	42.1	13.1	81.0	272.6	150.4
ALDH3A2	"ALDH10, FALDH, SLS"	ENSG00000072210	"Aldehyde dehydrogenase 3 family member A2"	P51648	17	19648136-19685760	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease variant, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 288.6"	"Cell type enhanced"	"Detected in all"		"Basal squamous epithelial cells: 287.4;Squamous epithelial cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 285.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014769, CAB020692"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"		NA	NA		32000	"Cluster 14: Monocytes - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Endoplasmic reticulum, Cytosol"		"CAB020692: , HPA014769: AB_1844728"	"unprognostic (1.42e-1)"	"unprognostic (7.62e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.93e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (3.85e-8)"	"unprognostic (4.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.26e-1)"	75.2	203.0	23.1	15.2	32.5	9.3	34.9	24.8	27.7	49.4	71.7	49.6	68.1	29.4	41.7	131.3	38.3	70.5	44.6	29.0	27.9	173.0	288.6	59.1	14.9	23.3	26.3	32.3	52.3	40.6	21.9	11.8	23.5	75.0	36.5	40.8	61.7	41.5	53.0	207.6	71.8	30.2	25.1	19.4	81.5	26.9	24.8	23.0	75.1	100.9	36.4	24.2	40.5	33.6	27.7	147.0	29.2	58.5	88.7	89.4	19.1	12.3	29.9	24.4	27.6	63.2	52.5	12.3	35.9	50.5	29.3	99.0	59.8	125.2	19.9	36.2	42.5	5.3	120.9	142.8	12.2	30.6	5.4	42.9	137.6	22.9	12.2	49.7	49.2	25.5	2.2	0.6	37.3	45.3	0.7	25.2	32.3	285.4	78.5	38.6	64.1	25.3	17.5	132.3	46.3	30.4	98.9	38.4	35.3	152.2	78.1	35.0	46.7	10.1	28.7	68.8	45.6	11.3	28.6	15.5	47.4	0.3	48.3	0.8	21.1	17.5	6.3	18.3	9.9	5.2	6.0	6.1	20.7	4.9	6.8	6.3	2.2	15.0	20.6	1.3	11.3	11.0	23.1	32.5	24.8	27.7	29.0	27.9	23.3	26.3	23.5	25.1	24.8	33.6	22.1	176.3	86.5	14.7	13.3	57.1	143.9	85.1	287.4	15.3	13.6	24.0	54.1	105.8	86.5	33.1	12.5	12.5	8.2	48.9	43.0	97.5	79.6	47.5	13.4	19.5	16.2	8.2	30.5	52.0	4.6	39.9	87.7	36.9	29.7	34.6	13.6	116.7	24.6	6.7	20.1	27.7	26.4	21.7	15.1	19.5	55.9	23.5	7.2	13.1	25.7	105.9	8.2	19.6	29.1	43.9	28.7	80.5	28.6	104.2	90.6	119.2	59.2	21.4	13.1	70.1	22.1	15.5	24.0	232.6	90.2	1.4	13.2	29.1	46.0	51.4
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595362	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 162.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 414.1;Proximal tubular cells: 302.1;Syncytiotrophoblasts: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 6.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 256.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023296, HPA053675"	Enhanced		Supported	Mitochondria,Cytosol		Yes	No		430000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria	Cytosol	"HPA023296: AB_1844738, HPA053675: "	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	23.7	38.3	46.6	9.1	47.6	1.8	47.1	43.7	45.8	32.7	40.7	29.5	23.7	25.1	8.8	35.9	28.8	19.1	27.9	44.7	43.2	115.1	162.2	15.7	8.6	43.1	43.5	65.3	27.0	34.0	8.8	44.9	42.6	42.0	27.4	19.7	40.6	27.9	12.2	29.4	21.0	23.6	44.8	7.0	23.6	12.3	44.0	18.3	47.6	26.5	17.1	18.1	20.9	45.2	64.9	41.9	116.6	193.4	95.5	56.4	147.8	76.1	93.4	86.5	110.5	118.6	60.7	0.0	75.5	60.0	36.1	47.1	36.5	256.2	78.8	0.1	44.6	12.3	63.1	102.1	46.3	0.2	0.0	69.0	59.2	67.3	47.7	64.2	70.0	0.0	0.0	0.1	77.1	42.1	2.6	0.3	79.4	47.5	35.2	38.9	131.8	0.0	81.2	48.4	39.4	47.2	0.0	41.1	44.7	89.0	75.2	2.7	86.1	24.8	75.6	28.8	53.1	0.1	0.1	0.4	13.4	0.2	40.6	0.7	0.2	0.1	0.1	0.0	0.2	0.8	0.2	0.1	1.8	0.6	1.2	0.6	0.1	0.1	0.0	6.4	0.0	0.4	46.6	47.6	43.7	45.8	44.7	43.2	43.1	43.5	42.6	44.8	44.0	45.2	17.6	16.0	29.3	99.3	5.0	25.9	59.5	110.0	87.0	23.6	40.6	91.1	39.9	27.1	43.5	42.3	22.9	414.1	3.7	15.2	76.3	43.5	31.4	18.7	44.3	19.1	21.7	5.2	16.0	13.8	107.8	34.0	27.0	21.4	7.0	50.4	18.9	74.6	51.1	25.2	21.5	25.9	20.3	9.4	7.6	41.7	25.4	9.1	55.2	12.2	7.5	102.1	0.0	41.7	30.0	12.6	15.6	37.2	2.0	27.5	23.4	302.1	23.4	13.6	19.7	19.4	25.8	1.0	5.1	59.2	16.1	222.3	4.6	39.3	46.4	50.4
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 311.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	119.2	105.5	49.6	29.8	51.0	24.8	76.8	49.3	60.3	51.5	62.5	45.7	54.8	38.6	93.4	105.6	50.2	32.0	48.2	47.4	57.5	142.4	206.5	38.5	40.3	50.5	52.1	53.6	44.0	81.9	39.9	38.0	51.4	65.3	50.6	46.4	104.1	45.6	93.6	54.7	48.6	42.0	50.7	37.9	39.5	63.4	49.3	39.0	123.0	56.4	60.1	39.4	43.9	55.6	55.7	53.5	48.7	44.1	152.1	132.8	40.7	71.9	101.5	70.8	61.0	33.4	40.7	0.1	67.1	64.8	34.9	42.8	40.0	70.3	83.0	25.9	50.6	35.3	34.7	36.5	78.2	56.0	36.1	86.0	34.8	75.2	62.5	97.8	62.2	45.9	56.9	48.4	111.7	33.4	37.6	57.6	71.3	145.1	64.7	31.7	62.0	74.3	92.5	52.0	57.7	39.8	51.4	57.1	67.4	65.6	108.8	84.0	61.9	42.5	41.5	52.4	37.1	44.7	62.5	54.8	47.9	52.6	41.7	61.8	35.2	50.9	45.5	37.7	48.8	49.9	43.8	49.6	34.5	46.8	43.8	50.4	51.3	43.0	45.3	21.6	69.8	45.6	49.6	51.0	49.3	60.3	47.4	57.5	50.5	52.1	51.4	50.7	49.3	55.6	56.2	16.0	47.6	12.7	43.3	32.6	43.3	43.8	68.3	25.0	83.0	54.6	46.5	55.8	36.8	51.5	22.9	48.5	39.3	43.9	97.8	42.9	45.4	27.7	39.1	49.4	55.8	28.2	5.6	37.0	76.4	60.6	36.2	20.4	38.0	60.9	59.3	158.8	61.9	13.5	8.3	56.9	32.6	59.1	24.9	39.8	95.4	43.8	56.9	6.5	34.6	311.5	39.1	12.1	12.2	32.2	33.1	115.5	34.8	39.6	80.3	204.4	59.4	28.9	26.3	32.5	40.1	85.6	49.9	123.8	51.9	38.2	43.7	148.4	63.6	28.3
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200586014-200677064	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 300.5;liver: 891.0"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 749.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 377.3;ASC TERT1: 191.5;HSkMC: 78.2;hTERT-HME1: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA040199, HPA040215"	Enhanced					NA	NA		3300000		"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favorable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	87.6	300.5	0.6	3.2	2.9	0.5	50.2	0.1	2.4	17.9	3.6	12.0	0.8	10.8	12.3	8.2	48.2	9.9	14.9	1.1	1.5	103.2	891.0	19.5	4.7	1.3	1.0	48.0	85.0	1.3	2.8	1.7	1.2	22.3	4.5	0.5	15.3	28.3	12.9	20.1	12.7	7.1	0.5	4.1	14.3	19.4	4.0	2.0	17.7	11.0	1.5	38.6	17.7	3.6	0.6	0.2	0.0	0.0	377.3	191.5	0.2	6.6	12.2	5.4	9.7	0.0	0.1	0.1	0.5	8.4	2.3	0.2	0.1	18.6	22.0	0.2	0.6	0.0	4.6	20.7	25.4	0.9	0.0	78.2	4.6	26.1	81.2	5.4	0.2	0.2	0.2	0.1	18.3	0.5	0.0	0.1	8.0	0.1	5.2	0.0	0.5	0.1	0.2	0.2	0.4	0.3	4.8	0.0	0.3	0.4	0.1	0.2	31.9	13.8	11.2	0.2	2.5	0.2	0.1	2.6	10.7	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.9	0.1	2.4	1.1	1.5	1.3	1.0	1.2	0.5	4.0	3.6	1.0	3.2	1.1	0.7	3.6	1.8	0.5	1.2	1.2	0.1	0.2	0.3	0.9	17.2	0.1	3.7	0.0	0.1	0.0	0.1	11.7	0.7	0.8	0.4	3.0	2.6	3.0	37.5	0.9	26.2	0.2	22.9	0.0	8.2	0.0	0.1	15.4	749.1	0.4	0.0	2.5	0.1	2.0	19.8	3.6	4.4	74.0	1.7	3.6	1.0	0.0	0.6	0.0	5.0	6.9	11.5	0.0	82.0	0.0	7.5	0.1	162.2	0.1	0.1	0.0	5.3	3.0	0.8	1.3	0.1	1.6	0.0	2.0	2.3	0.1	0.4
AP000812.3		ENSG00000284844	"Novel protein, ortholog of mouse Tomt"		11	72105924-72109329	"Metabolic proteins, Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																											0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASMT	"ASMTY, HIOMT, HIOMTY"	ENSG00000196433	"Acetylserotonin O-methyltransferase"	P46597	X	1615059-1643081	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Melatonin biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.8;Early spermatids: 1.1;Excitatory neurons: 1.5;Extravillous trophoblasts: 1.0;Inhibitory neurons: 1.3;Oligodendrocytes: 1.3;Theca cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"		"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.84e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.79e-3)"	0.4	0.8	0.6	0.3	0.6	0.7	0.4	0.6	0.9	0.8	1.4	0.5	0.0	0.6	1.8	0.2	0.5	0.2	0.4	0.6	1.1	0.3	0.3	0.3	0.2	0.4	0.4	0.4	0.4	0.1	1.4	0.1	0.4	0.5	0.0	0.4	0.3	0.2	0.2	0.4	0.4	0.2	0.3	0.6	0.4	0.4	0.5	0.1	0.5	0.1	0.1	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.6	0.0	2.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.9	0.6	1.1	0.4	0.4	0.4	0.3	0.5	0.6	0.2	0.0	1.8	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.1	0.2	0.0	0.0	1.5	0.0	1.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.1	0.5	3.4	0.0	0.1
CHST10	HNK-1ST	ENSG00000115526	"Carbohydrate sulfotransferase 10"	O43529	2	100391860-100417668	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 21.5;Muller glia cells: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012884, HPA051545"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		680000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA012884: AB_1846710, HPA051545: AB_2681529"	"unprognostic (5.40e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (4.05e-4)"	"unprognostic (8.02e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.27e-1)"	4.3	6.7	26.5	4.2	28.2	3.2	5.1	24.3	33.6	7.1	18.8	6.3	2.3	11.5	13.3	4.2	9.7	5.5	11.0	27.2	23.2	4.3	1.2	8.1	4.4	24.6	26.4	12.7	5.6	9.6	11.5	8.2	23.2	8.0	2.4	9.4	6.1	5.2	6.0	2.2	3.6	12.0	24.8	5.0	4.4	6.1	28.6	5.7	10.0	8.3	5.4	5.5	3.7	25.1	0.2	14.6	28.4	14.6	8.5	11.9	14.2	16.7	11.8	22.4	14.3	0.3	8.5	20.4	14.1	10.1	39.6	0.0	20.2	2.2	14.3	29.1	21.2	10.5	8.3	23.1	10.1	21.5	26.5	8.8	2.7	10.6	2.0	10.7	17.8	19.5	31.0	0.1	9.7	4.8	19.1	16.8	42.0	0.2	17.7	13.6	17.6	0.2	6.2	6.4	30.5	24.9	1.2	0.1	23.3	20.0	7.8	29.0	16.4	15.5	24.5	11.7	15.7	0.0	0.1	21.2	19.0	18.7	18.6	0.0	0.0	0.0	1.3	0.0	0.4	0.8	0.2	1.0	0.2	0.6	0.3	0.7	0.0	0.0	0.0	1.1	0.0	0.5	26.5	28.2	24.3	33.6	27.2	23.2	24.6	26.4	23.2	24.8	28.6	25.1	2.8	16.0	3.1	21.5	4.4	0.9	1.1	0.3	0.6	9.7	2.4	2.0	6.3	1.5	4.4	1.8	0.0	5.4	2.3	0.0	3.9	3.5	1.5	2.7	6.7	4.9	1.8	3.0	10.7	2.9	10.5	5.0	0.0	6.2	0.0	6.5	0.4	0.0	6.2	6.7	7.5	0.0	0.0	0.8	1.1	0.4	2.1	1.3	0.0	6.5	3.2	16.7	1.0	12.5	5.9	2.2	0.0	5.3	2.3	1.5	0.0	1.1	0.7	4.8	0.0	3.7	3.5	1.5	5.1	0.3	0.6	1.4	3.4	8.5	0.1	0.2
CHST2	C6ST	ENSG00000175040	"Carbohydrate sulfotransferase 2"	Q9Y4C5	3	143119771-143124014	"Metabolic proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 114.4;NK-cells: 233.8;Plasma cells: 79.3;Sertoli cells: 92.1;Theca cells: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 4.3;NK-cell: 4.9;non-classical monocyte: 11.4"	"Group enriched"	"Detected in many"	5	"monocytes: 11.4;NK-cells: 4.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 57.7;ASC TERT1: 58.8;HEL: 48.2;HHSteC: 118.4;HMC-1: 55.4;HSkMC: 62.3;U-266/70: 52.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013620			Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA013620: AB_2668861"	"unprognostic (1.55e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.75e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.11e-2)"	"unprognostic (8.96e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.34e-1)"	7.7	2.7	17.8	8.1	13.7	16.8	6.3	16.7	14.6	5.7	6.0	3.0	2.1	8.4	1.4	1.1	2.1	1.7	5.6	9.7	13.4	8.4	1.3	7.5	7.7	31.0	18.4	4.9	1.3	0.9	6.9	10.3	28.1	7.4	1.1	11.0	2.7	9.9	1.6	4.4	7.5	3.7	21.4	18.2	3.4	1.7	28.7	14.5	6.7	0.8	5.4	7.1	7.6	48.4	0.0	0.3	3.1	2.6	57.7	58.8	0.2	3.3	9.5	2.3	2.1	0.0	0.0	0.6	2.0	2.3	3.1	0.1	2.3	8.2	1.2	0.8	1.5	48.2	0.1	0.0	118.4	1.2	55.4	62.3	9.7	3.1	10.1	3.6	3.6	7.2	5.5	2.9	15.4	0.0	9.1	12.2	16.5	0.0	8.0	0.5	1.0	0.1	1.7	2.2	3.7	0.0	0.7	0.0	5.6	2.9	0.0	1.9	12.3	7.0	4.1	9.5	13.9	52.4	0.8	3.3	13.8	9.3	37.4	0.7	0.5	0.7	0.3	4.3	0.0	1.1	0.1	0.2	1.6	0.8	0.6	0.5	0.3	4.9	11.4	0.1	0.5	0.9	17.8	13.7	16.7	14.6	9.7	13.4	31.0	18.4	28.1	21.4	28.7	48.4	11.3	0.0	0.0	3.6	17.7	2.4	7.3	2.5	0.0	25.0	2.8	2.7	1.4	0.0	1.8	3.7	2.1	0.6	41.9	0.0	0.0	0.4	0.2	5.7	29.8	9.4	0.0	39.1	6.8	0.2	0.6	14.4	2.0	6.5	11.4	12.5	3.6	0.4	2.8	1.7	8.1	0.0	0.0	10.3	32.2	1.3	12.8	20.2	17.8	1.0	13.6	114.4	233.8	2.5	6.1	5.9	0.0	2.2	79.3	13.1	0.0	0.0	0.1	23.8	92.1	0.8	20.2	0.0	2.2	0.1	0.6	1.0	9.8	58.1	1.3	14.8
CHST4	"HEC-GLCNAC-6-ST, LSST"	ENSG00000140835	"Carbohydrate sulfotransferase 4"	Q8NCG5	16	71525233-71538748	"Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Inflammatory response"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"gallbladder: 69.4"	"Cell type enriched"	"Detected in some"	24	"Cholangiocytes: 165.8"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 10.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.6;HL-60: 2.7;NB-4: 5.0;NTERA-2: 7.5;SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021955	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA021955: AB_1846723"	"unprognostic (2.22e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.87e-2)"	"unprognostic (3.35e-2)"	"unprognostic (4.76e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (1.26e-1)"		"unprognostic (1.70e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-6)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.73e-1)"	0.4	1.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	2.5	1.7	0.0	0.0	0.1	0.0	0.2	5.4	69.4	0.0	0.2	0.1	0.0	4.4	0.2	1.3	0.4	0.6	0.0	12.4	0.0	0.5	0.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.1	0.2	0.0	0.0	1.9	0.0	0.0	0.1	1.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.3	0.1	0.0	0.3	0.1	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	7.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	2.1	0.1	1.5	0.0	0.0	1.6	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.6	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.1	165.8	6.7	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.7	0.4	0.0	0.0	0.0	0.4	0.7	0.0	0.3	0.0	3.8	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CHST5	"FLJ22167, I-GLCNAC-6-ST"	ENSG00000135702	"Carbohydrate sulfotransferase 5"	Q9GZS9	16	75528535-75535247	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 85.0"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 5.2;Intestinal goblet cells: 3.7;Paneth cells: 8.1;Proximal enterocytes: 11.6;Undifferentiated cells: 2.6"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.4;stomach cancer: 1.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 1.5"									"HPA043804, HPA068029"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA043804: AB_10960563, HPA068029: "	"unprognostic (6.82e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-2)"		"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.03e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.42e-2)"	0.1	0.2	2.2	1.3	2.0	0.6	0.4	1.9	2.2	0.4	2.2	46.1	85.0	0.4	0.3	0.2	1.1	0.2	0.3	2.2	1.0	0.4	0.1	0.3	0.3	1.9	1.5	0.5	0.1	0.4	0.7	0.2	0.7	0.3	55.3	1.5	0.1	0.3	7.7	0.2	75.6	1.0	1.2	0.4	4.7	0.7	1.8	0.3	0.3	0.8	0.1	0.2	0.1	1.6	0.1	0.3	0.4	0.5	0.1	0.3	0.2	0.0	0.1	0.2	0.1	0.2	0.6	0.4	0.2	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.5	0.0	0.2	0.6	0.1	0.2	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.4	0.0	0.9	0.2	1.3	0.3	0.0	1.5	0.2	0.1	0.9	0.5	0.1	0.7	1.2	0.6	0.4	0.0	0.0	0.3	0.1	0.0	0.5	0.3	0.9	0.1	0.2	0.7	0.0	0.3	0.1	0.3	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.2	0.2	0.1	0.0	2.2	2.0	1.9	2.2	2.2	1.0	1.9	1.5	0.7	1.2	1.8	1.6	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.3	0.0	0.0	2.4	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	2.0	0.6	0.0	8.1	0.0	0.0	0.0	11.6	0.0	1.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0
CHST6	MCDC1	ENSG00000183196	"Carbohydrate sulfotransferase 6"	Q9GZX3	16	75472052-75495445	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Corneal dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 13.5;cervix: 9.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 60.0;Oligodendrocytes: 17.0;Respiratory ciliated cells: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 9.3;CAPAN-2: 9.9;NTERA-2: 4.8;SK-MEL-30: 4.1;U-2 OS: 5.0;WM-115: 5.4"									HPA068029	Approved				"Intracellular and membrane"	NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA068029: "	"unprognostic (2.28e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-3)"	"unprognostic (3.30e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.80e-4)"	0.1	5.4	8.6	0.2	11.8	0.1	0.0	8.5	7.9	9.4	3.4	0.8	4.5	0.4	0.2	1.3	1.2	0.1	1.9	7.2	10.7	0.3	0.0	0.9	0.1	12.5	13.2	0.0	0.0	0.2	1.2	0.1	11.5	0.4	1.5	0.3	2.7	0.1	0.1	0.1	3.9	0.3	10.9	0.1	0.1	0.8	13.5	0.1	0.1	0.1	0.0	0.2	0.1	11.7	0.1	0.5	0.6	9.3	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.2	9.9	0.1	1.1	0.0	0.1	0.1	0.9	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	4.8	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	4.1	1.4	0.0	0.3	0.1	0.0	5.0	0.0	0.0	0.1	0.1	2.1	0.2	0.0	5.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	8.6	11.8	8.5	7.9	7.2	10.7	12.5	13.2	11.5	10.9	13.5	11.7	0.2	0.0	2.4	7.5	0.2	0.0	1.7	0.7	0.0	0.7	0.2	0.1	1.0	0.0	4.8	3.7	0.0	2.1	0.1	3.8	0.0	0.1	1.3	60.0	0.8	0.4	0.0	0.0	0.4	0.0	0.2	1.6	0.0	7.5	1.3	0.2	0.0	0.0	0.2	0.0	1.3	4.0	0.0	0.0	0.0	1.3	0.0	0.4	0.0	1.9	0.0	0.6	0.0	6.0	17.0	0.2	8.9	0.0	0.0	1.5	8.9	0.0	16.4	0.4	0.0	1.0	0.7	0.3	0.6	0.0	0.0	0.7	0.4	0.1	2.2	3.9
CHST7	"C6ST-2, C6ST2"	ENSG00000147119	"Carbohydrate sulfotransferase 7"	Q9NS84	X	46573765-46598496	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 35.3"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 45.4;monocytes: 55.5;Peritubular cells: 60.2;Sertoli cells: 52.6;Skeletal myocytes: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 18.5"	"Group enriched"	"Detected in many"	10	"granulocytes: 10.9;monocytes: 10.2;T-cells: 18.5"	"Cell line enhanced"	"Detected in many"		"EFO-21: 22.8;NTERA-2: 20.5;PC-3: 17.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003919, HPA030503"	Approved		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		9800	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Vesicles"		"HPA003919: AB_10601258, HPA030503: "	"unprognostic (3.16e-1)"	"prognostic favorable (7.20e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.85e-2)"	"unprognostic (9.82e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.39e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.85e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.39e-2)"	13.2	3.4	5.4	1.7	7.3	2.5	7.5	6.4	7.0	11.2	3.7	3.7	0.8	5.8	0.4	2.5	4.9	1.9	17.4	5.4	7.1	4.0	7.5	3.6	1.8	6.1	7.3	35.3	2.0	1.2	4.2	2.0	6.0	4.1	0.8	0.9	3.5	1.4	4.4	7.3	4.0	1.4	4.7	10.2	3.4	2.1	8.0	1.4	5.8	3.9	0.7	4.5	7.7	4.0	5.5	4.7	3.9	3.5	10.8	7.5	0.2	7.6	5.4	2.0	2.6	1.2	2.1	0.0	22.8	3.1	1.3	4.1	3.8	1.3	1.7	3.2	8.1	1.1	0.3	4.1	16.6	1.9	0.1	2.5	1.1	3.8	3.1	3.4	6.2	2.5	0.0	4.7	1.5	2.6	0.7	2.4	20.5	0.4	17.0	3.6	3.2	10.3	5.5	0.2	8.8	3.4	1.1	0.2	0.9	9.6	1.3	0.4	1.4	6.1	0.6	3.3	3.5	11.0	2.4	1.7	6.8	0.1	0.4	2.4	2.2	0.7	1.5	7.1	1.4	1.2	5.8	2.8	1.2	0.6	1.2	1.1	10.9	0.6	10.2	0.8	18.5	1.9	5.4	7.3	6.4	7.0	5.4	7.1	6.1	7.3	6.0	4.7	8.0	4.0	33.8	0.0	3.1	22.9	2.5	12.4	2.0	4.8	1.2	0.8	2.2	3.7	7.4	10.0	2.6	1.8	0.0	5.3	11.5	1.7	1.9	2.8	0.0	3.6	20.8	16.3	0.0	0.0	0.9	2.5	4.3	23.6	0.0	1.6	0.0	19.7	15.7	4.5	11.5	3.3	4.1	2.9	0.0	14.2	45.4	0.3	19.0	14.1	14.2	4.7	55.5	5.2	4.1	13.0	1.0	1.8	1.5	60.2	4.7	6.7	0.7	2.1	1.9	0.8	52.6	43.1	11.2	0.5	1.3	1.3	13.2	1.4	9.9	11.4	0.9	3.3
CHST8	GALNAC-4-ST1	ENSG00000124302	"Carbohydrate sulfotransferase 8"	Q9H2A9	19	33621953-33773509	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"brain: 30.3;pituitary gland: 63.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Excitatory neurons: 11.8;Granulosa cells: 7.9;Late spermatids: 56.5;Oligodendrocyte precursor cells: 12.1"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;glioma: 4.9;testis cancer: 3.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 24.7;SCLC-21H: 13.5;SH-SY5Y: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA016004	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA016004: AB_1846731"	"unprognostic (1.00e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.98e-8)"	"unprognostic (9.37e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.87e-2)"	0.7	0.7	7.8	0.3	6.7	0.0	1.8	11.5	10.4	0.9	0.1	0.4	0.0	0.6	0.0	0.3	1.2	0.9	0.4	11.0	11.4	0.1	0.1	0.2	0.4	29.8	7.2	1.0	0.7	0.0	63.9	0.0	30.3	0.7	0.0	0.7	0.2	0.0	0.1	0.3	0.3	0.1	5.4	1.3	0.3	1.4	11.5	0.0	0.6	0.0	0.2	0.3	0.5	8.2	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	4.7	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.6	0.0	0.0	0.0	0.1	24.7	0.0	0.4	13.5	23.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.8	6.7	11.5	10.4	11.0	11.4	29.8	7.2	30.3	5.4	11.5	8.2	0.2	0.0	0.0	0.7	0.0	0.8	0.4	0.0	0.0	3.1	3.8	0.6	5.1	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.3	0.2	0.4	0.0	0.0	11.8	0.0	1.3	0.2	0.0	0.1	0.0	7.9	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	56.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	12.1	3.6	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.7	0.0	0.3	3.2	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.0	1.1
CHST9	"GALNAC-4-ST2, GALNAC4ST-2"	ENSG00000154080	"Carbohydrate sulfotransferase 9"	Q7L1S5	18	26906481-27185308	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 13.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 115.2;Muller glia cells: 69.2;Oligodendrocyte precursor cells: 167.4;Respiratory ciliated cells: 311.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;Hep G2: 13.8;RPTEC TERT1: 41.8;SCLC-21H: 9.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA011393	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA011393: AB_1846733"	"unprognostic (9.24e-3)"	"unprognostic (1.13e-2)"		"unprognostic (4.81e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.53e-3)"	"unprognostic (9.98e-3)"	"unprognostic (9.21e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"		"unprognostic (3.93e-3)"	0.0	0.2	0.8	0.1	0.9	0.0	2.9	0.7	2.4	2.8	0.0	1.6	0.2	0.1	0.4	1.6	10.3	3.1	2.6	2.7	1.2	1.6	8.2	4.3	0.0	3.5	2.3	0.0	9.3	0.0	1.9	0.0	1.2	3.5	0.2	7.3	13.8	1.8	0.2	0.1	0.3	0.1	2.0	5.7	0.7	6.9	1.2	1.0	0.0	0.9	0.6	1.5	0.7	1.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	41.8	0.0	9.0	0.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.7	2.4	2.7	1.2	3.5	2.3	1.2	2.0	1.2	1.9	0.1	0.0	2.7	24.8	0.0	0.6	32.6	56.6	4.6	1.3	8.2	8.0	9.2	35.8	115.2	5.5	0.0	0.4	0.1	0.0	11.7	13.0	7.1	49.9	0.7	0.3	3.5	0.0	10.1	0.6	0.1	4.2	0.0	1.8	5.1	0.1	0.0	10.7	0.3	0.0	29.3	0.1	22.4	0.0	0.0	4.4	0.6	0.5	7.2	1.0	0.0	69.2	0.0	167.4	1.0	1.3	0.0	0.4	0.0	8.9	0.0	0.3	311.6	3.2	0.0	3.2	3.7	0.9	1.3	4.7	0.0	0.3	0.4	0.0	0.0	40.3
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941371-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 885.9;Syncytiotrophoblasts: 648.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 818.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"		NA	NA		43000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favorable (5.67e-4)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	78.1	180.7	99.3	39.6	108.9	71.8	85.5	114.4	140.4	105.3	119.6	80.1	55.0	76.9	47.7	198.0	65.2	60.3	81.7	96.6	107.4	94.2	292.3	93.3	49.7	117.4	107.9	107.4	74.0	61.5	48.7	116.9	117.3	87.2	20.7	17.2	133.7	70.5	98.6	119.7	64.1	38.3	109.2	63.6	99.8	51.7	102.7	26.9	59.1	49.9	26.0	86.9	124.1	124.3	131.3	131.7	15.0	128.3	141.2	122.5	6.0	143.9	178.8	120.3	133.6	112.1	148.6	51.7	62.7	208.9	48.6	172.9	23.6	152.0	26.2	115.1	163.4	92.5	65.1	267.1	265.1	155.0	35.3	159.2	180.7	104.3	101.3	116.6	113.2	82.0	383.2	109.4	100.6	818.5	63.4	267.9	32.4	361.1	42.9	88.2	127.9	72.8	129.0	404.5	60.4	53.8	47.7	405.7	125.7	7.6	84.0	436.6	137.5	212.7	82.2	71.0	109.6	37.5	18.0	41.2	236.0	211.3	152.5	62.2	312.2	59.6	77.9	218.1	64.0	56.8	52.6	62.6	251.5	57.8	45.5	51.7	12.0	73.5	151.5	291.4	72.6	178.6	99.3	108.9	114.4	140.4	96.6	107.4	117.4	107.9	117.3	109.2	102.7	124.3	99.1	125.0	88.1	22.9	33.1	102.1	231.9	248.1	188.4	73.4	174.9	218.4	41.9	104.4	162.7	152.6	10.4	885.9	80.1	53.0	320.8	201.0	4.6	59.1	72.2	86.7	84.5	70.0	16.8	193.0	113.5	103.1	46.4	46.9	71.7	95.7	77.1	262.0	311.4	25.2	17.2	97.7	191.2	177.0	107.7	13.3	134.2	137.0	240.1	20.6	137.0	158.7	41.2	25.1	45.7	170.2	108.8	179.8	45.5	132.4	179.9	73.8	135.8	43.2	138.1	143.3	113.1	8.4	5.7	236.4	123.5	648.5	41.8	222.0	122.3	206.6
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725536	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 66.1;urinary bladder: 63.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 21.9;Endothelial cells: 13.7;Glandular and luminal cells: 5.9;Hepatocytes: 9.9;Urothelial cells: 16.4"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;hTCEpi: 19.5;HUVEC TERT2: 19.1;SK-BR-3: 14.7;SuSa: 35.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB018654	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	18.5	0.6	0.2	0.0	0.2	0.0	14.7	0.1	0.3	3.6	0.0	2.0	0.6	2.4	0.6	1.9	1.2	0.7	10.7	0.2	0.4	1.4	66.1	12.2	0.0	0.3	0.4	0.5	0.6	0.0	0.5	0.3	0.3	0.7	0.1	0.3	1.8	0.6	4.1	13.9	19.8	0.0	0.1	0.1	1.8	0.3	0.2	0.2	2.0	0.2	0.1	63.6	2.2	0.1	0.3	2.1	0.2	0.0	0.5	0.1	11.7	0.0	0.1	0.7	0.3	36.9	1.6	0.3	9.6	0.0	8.8	11.4	0.7	7.3	0.3	0.0	1.0	0.5	2.6	5.5	0.2	0.3	11.5	0.0	19.5	0.3	1.4	0.4	19.1	0.3	2.3	0.3	0.1	0.7	0.1	0.4	0.2	12.1	2.9	1.2	0.0	0.4	0.0	2.4	0.6	0.3	1.7	14.7	3.8	35.6	0.4	0.2	1.0	1.6	0.5	5.2	0.0	0.7	0.2	0.5	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.2	0.4	0.3	0.4	0.3	0.1	0.2	0.1	21.9	0.0	0.0	0.0	0.1	0.5	2.4	0.0	0.0	0.0	0.4	0.5	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.4	1.1	13.7	0.0	0.0	0.1	0.2	0.0	0.2	0.0	5.9	0.0	0.0	0.0	9.9	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.0	16.4
CYP1A2	"CP12, P3-450"	ENSG00000140505	"Cytochrome P450 family 1 subfamily A member 2"	P05177	15	74748845-74756607	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	313	"liver: 513.4"	"Cell type enriched"	"Detected in some"	57	"Hepatocytes: 85.7"	"Group enriched"	"Detected in some"	22	"liver cancer: 25.3;urothelial cancer: 6.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB016531	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"			"CAB016531: AB_629359"				"unprognostic (1.54e-4)"			"unprognostic (1.29e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.59e-2)"		"unprognostic (1.76e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.53e-1)"	0.2	0.3	0.5	0.2	0.5	1.0	0.1	1.6	0.8	0.0	0.2	0.0	0.2	0.2	0.4	0.1	0.2	0.2	0.1	0.5	0.5	0.2	513.4	0.4	0.3	0.6	0.5	0.1	0.0	0.0	0.0	0.7	0.6	0.1	0.1	0.4	0.2	0.3	0.3	0.6	0.2	0.0	0.1	0.3	0.2	0.3	0.6	0.1	1.4	0.0	0.1	0.1	0.0	1.3	0.4	0.3	0.8	0.5	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.4	0.8	0.1	0.0	0.6	0.4	0.0	0.0	0.0	0.1	0.4	0.9	0.6	0.1	0.0	0.7	0.3	0.1	0.1	0.0	0.0	0.3	0.1	1.3	0.7	1.3	0.0	0.2	0.9	0.3	0.4	0.3	0.2	0.9	0.8	0.3	0.1	0.7	0.7	0.3	0.6	2.3	0.1	0.6	0.5	0.2	0.2	0.3	0.4	0.3	0.3	0.3	0.2	0.5	0.3	0.9	0.3	1.5	0.3	0.5	0.2	0.2	0.1	0.3	0.2	0.1	0.1	0.5	0.2	0.2	2.1	0.4	0.2	0.4	0.1	0.1	0.5	0.5	1.6	0.8	0.5	0.5	0.6	0.5	0.6	0.1	0.6	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	85.7	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2
CYP1B1	"CP1B, GLC3A"	ENSG00000138061	"Cytochrome P450 family 1 subfamily B member 1"	Q16678	2	38066973-38109902	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism, Steroid metabolism"	"Lyase, Monooxygenase, Oxidoreductase"	"Disease variant, Glaucoma, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Peritubular cells: 170.8;Prostatic glandular cells: 747.6;Urothelial cells: 498.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"classical monocyte: 156.9"	"Lineage enriched"	"Detected in many"	24	"monocytes: 156.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 128.7;ASC TERT1: 136.8;HSkMC: 551.3;hTERT-RPE1: 128.9;SiHa: 270.0;U-87 MG: 142.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 34.6"	"CAB011705, HPA026863"	Approved		Uncertain	Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB011705: AB_731810, HPA026863: AB_10600900"	"unprognostic (7.25e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.87e-3)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (2.76e-4)"	28.4	12.0	2.7	31.9	6.2	2.0	29.4	1.6	8.9	34.9	10.4	3.7	2.2	41.0	19.5	7.6	44.9	23.8	29.2	2.5	2.3	24.1	7.0	16.8	11.6	3.6	2.9	5.6	7.2	0.9	14.8	4.5	3.0	34.7	2.1	1.2	4.3	39.2	3.4	6.3	5.8	35.1	3.6	27.3	15.9	8.0	7.3	28.3	8.7	5.5	1.9	35.0	6.7	1.5	7.0	71.9	2.3	0.0	128.7	136.8	0.4	0.6	4.4	1.3	12.3	0.2	30.1	0.0	19.1	17.8	3.1	58.7	0.3	4.0	2.3	5.5	3.8	0.0	21.2	0.0	36.0	0.2	0.1	551.3	55.3	30.7	1.4	128.9	0.0	0.3	0.7	0.2	0.7	29.2	0.3	22.5	7.5	10.4	14.2	0.1	0.0	0.2	13.4	0.9	0.5	2.1	270.0	38.8	0.0	7.5	49.4	10.8	0.0	1.1	0.2	107.9	0.1	0.3	0.2	0.0	142.2	0.1	11.8	1.6	156.9	0.0	0.1	23.2	0.0	0.1	0.1	0.0	1.5	0.0	0.1	0.1	6.5	0.1	18.6	0.7	0.1	70.2	2.7	6.2	1.6	8.9	2.5	2.3	3.6	2.9	3.0	3.6	7.3	1.5	56.8	19.2	66.3	0.0	1.7	17.7	118.4	86.9	8.0	0.7	18.3	42.0	3.4	0.0	79.7	46.0	0.0	0.3	1.1	0.9	15.6	6.0	15.1	11.7	100.4	103.8	1.8	0.0	4.5	0.5	0.8	114.1	3.6	28.2	3.8	0.1	7.5	12.2	12.6	0.0	0.3	1.3	4.1	103.0	50.6	12.1	159.7	112.2	17.8	64.6	140.1	1.6	3.1	0.0	0.2	0.6	0.1	170.8	0.3	747.6	0.1	1.6	11.2	0.5	19.7	4.5	32.7	12.6	2.6	2.4	14.2	0.3	2.4	1.3	1.0	498.7
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565405	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Decarboxylase, Lyase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.8;kidney: 314.9;retina: 175.6"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 410.3;Proximal enterocytes: 391.5;Proximal tubular cells: 429.5;Rod photoreceptor cells: 498.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.5;liver cancer: 13.4;pancreatic cancer: 6.4;renal cancer: 18.7;stomach cancer: 9.9"	"Group enriched"	"Detected in many"	9	"midbrain: 86.3;pons: 29.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"CACO-2: 54.5;Hep G2: 49.3;OE19: 83.6;SCLC-21H: 130.9;SH-SY5Y: 135.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"midbrain: 74.5;pons: 29.4"	HPA017742	Enhanced		Approved	"Actin filaments"		NA	NA		120000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Actin filaments"		"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.5	48.9	0.1	2.3	0.7	0.0	1.0	0.0	0.6	0.0	0.2	36.5	154.8	0.0	9.1	0.1	0.0	0.1	0.0	0.2	2.2	314.9	54.6	2.0	0.1	6.1	86.3	0.8	15.8	0.0	0.0	0.0	29.4	0.6	37.5	175.6	0.0	0.0	0.0	0.1	165.8	1.7	0.0	0.1	18.1	1.5	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	54.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	11.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	83.6	0.0	0.0	0.0	0.7	1.3	0.0	130.9	135.9	0.0	4.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.6	0.2	2.2	6.1	86.3	29.4	0.0	1.9	0.2	0.0	0.0	12.2	0.0	2.5	0.0	0.0	0.0	0.0	89.3	0.1	0.1	0.4	2.8	0.6	3.7	41.7	0.0	0.0	34.4	25.4	0.1	6.6	0.1	0.0	1.8	410.3	0.0	0.3	0.9	0.1	0.1	0.0	0.4	0.0	0.0	1.1	67.2	0.1	3.3	0.4	67.8	0.0	1.3	0.0	5.4	0.0	2.5	0.0	0.0	0.0	45.1	0.0	0.0	0.1	0.2	31.8	0.0	0.0	0.3	391.5	429.5	0.0	498.9	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.1	1.3	0.1	88.7	0.2
GAL3ST2	GP3ST	ENSG00000154252	"Galactose-3-O-sulfotransferase 2"	Q9H3Q3	2	241776822-241804287	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"intestine: 9.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.0;Oligodendrocyte precursor cells: 1.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 6.7;ovarian cancer: 4.9;stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Hep G2: 3.7;HMC-1: 10.5"	"Not detected"	"Not detected"							HPA071809	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA071809: AB_2686450"	"unprognostic (5.22e-3)"	"unprognostic (6.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.04e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.87e-11)"	"unprognostic (4.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.49e-1)"	0.5	0.3	0.4	0.8	0.3	0.2	0.0	0.0	0.6	0.5	0.0	9.4	0.0	0.1	0.0	0.0	0.5	0.4	0.1	0.2	0.3	0.3	0.5	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	3.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	3.7	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.6	0.2	0.3	0.5	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0
GAL3ST3	GAL3ST2	ENSG00000175229	"Galactose-3-O-sulfotransferase 3"	Q96A11	11	66040765-66049161	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.7;thyroid gland: 17.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.9;Cardiomyocytes: 3.6;Cone photoreceptor cells: 10.4;Excitatory neurons: 3.7;Horizontal cells: 5.0;Inhibitory neurons: 4.7;Oligodendrocyte precursor cells: 7.5;Rod photoreceptor cells: 15.4"	"Group enriched"	"Detected in many"	5	"glioma: 4.7;ovarian cancer: 5.5;thyroid cancer: 10.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 6.5;SH-SY5Y: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"							"prognostic unfavorable (6.53e-6)"	"unprognostic (1.24e-1)"			"unprognostic (3.30e-1)"		"unprognostic (1.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.29e-1)"	0.0	0.0	5.3	0.0	7.7	0.0	0.0	4.8	5.7	2.9	0.1	0.0	0.0	3.9	0.1	0.0	2.6	0.0	7.1	4.8	2.1	5.3	0.0	0.0	0.0	2.0	2.6	0.2	0.6	0.3	4.1	0.0	1.6	0.8	0.0	5.7	0.0	1.6	0.3	0.1	0.0	2.8	1.5	0.0	0.0	2.1	2.8	0.0	17.1	0.3	0.0	0.0	0.3	3.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.3	7.7	4.8	5.7	4.8	2.1	2.0	2.6	1.6	1.5	2.8	3.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	3.6	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	5.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	7.5	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	15.4	0.0	0.0	0.3	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GAL3ST4	FLJ12116	ENSG00000197093	"Galactose-3-O-sulfotransferase 4"	Q96RP7	7	100159244-100168617	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 27.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 37.2;Microglial cells: 23.4;Oligodendrocyte precursor cells: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 4.5;naive CD4 T-cell: 15.0;naive CD8 T-cell: 4.6;plasmacytoid DC: 4.7"	"Group enriched"	"Detected in many"	29	"dendritic cells: 4.7;T-cells: 15.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 43.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038137, HPA038138"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm	Cytosol	"HPA038137: AB_10697239, HPA038138: AB_2675854"	"unprognostic (4.22e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.44e-4)"	"unprognostic (8.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (3.98e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.36e-2)"	4.3	4.9	9.2	3.9	9.3	0.7	3.7	8.4	12.6	11.0	7.6	6.1	3.8	9.1	3.1	7.8	6.0	5.6	5.0	9.1	9.5	1.4	0.9	5.2	2.9	13.4	9.5	6.3	1.4	3.0	4.2	5.1	10.1	4.8	6.3	0.5	25.6	3.6	1.9	27.7	5.0	9.9	10.7	2.7	2.4	4.8	15.9	22.3	1.9	1.9	3.2	6.7	10.6	13.1	0.1	0.9	5.4	2.3	4.7	9.6	10.9	3.2	3.2	1.8	2.6	0.6	0.2	1.1	0.7	10.4	3.3	12.2	0.3	1.8	0.6	0.1	0.6	0.4	0.2	0.4	3.4	0.3	2.7	11.7	4.6	5.5	0.6	4.0	3.7	4.3	1.6	0.2	3.4	0.4	4.2	0.2	1.9	11.5	1.3	2.7	2.4	0.2	0.0	0.4	0.3	2.2	1.0	0.0	6.7	1.0	0.0	0.3	3.4	0.3	1.6	0.5	0.1	0.2	0.2	2.5	1.9	0.4	43.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	4.5	0.3	0.0	0.1	15.0	4.6	0.3	0.2	0.1	4.7	1.3	2.2	9.2	9.3	8.4	12.6	9.1	9.5	13.4	9.5	10.1	10.7	15.9	13.1	0.7	0.0	0.5	2.9	0.1	4.2	2.0	3.3	7.4	0.0	2.2	2.4	1.0	1.5	0.9	0.0	0.0	0.3	0.3	1.5	0.0	0.6	0.2	0.2	2.1	1.2	0.0	2.7	0.5	0.0	0.4	7.5	0.0	0.3	0.0	1.2	1.4	0.0	37.2	0.0	0.3	1.3	4.1	1.3	0.8	0.0	4.7	9.6	5.4	23.4	0.7	0.4	0.0	24.6	0.5	0.3	2.5	5.3	0.0	0.5	0.0	0.0	0.1	0.1	0.0	3.7	3.3	0.6	0.3	4.2	8.1	0.8	0.7	0.1	4.1	1.4
HS2ST1	KIAA0448	ENSG00000153936	"Heparan sulfate 2-O-sulfotransferase 1"	Q7LGA3	1	86914635-87109982	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.9;Excitatory neurons: 126.1;Inhibitory neurons: 130.1;Oligodendrocyte precursor cells: 95.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043069, HPA043603, HPA075001"	Supported		Approved	Mitochondria	"Intracellular and membrane"	No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA043069: AB_10964127, HPA043603: AB_10963432, HPA075001: AB_2686726"	"unprognostic (1.04e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.34e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (5.07e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.58e-2)"	8.0	25.7	11.5	9.4	13.8	3.8	8.1	8.0	12.2	10.5	13.2	9.3	9.7	9.1	9.9	7.0	6.7	10.6	7.0	11.9	11.4	13.8	17.2	8.2	11.8	10.1	11.0	12.7	10.1	13.4	6.6	8.3	8.1	9.5	9.0	19.3	6.7	9.9	4.4	8.2	9.3	7.8	8.8	12.7	8.3	9.3	12.2	10.6	12.9	4.7	11.6	9.4	5.9	8.4	24.4	20.4	59.0	38.5	31.9	92.3	20.4	23.3	30.5	19.2	21.2	78.1	30.6	53.3	22.1	16.4	33.2	14.5	27.2	19.5	30.8	42.1	22.2	64.0	21.0	63.0	13.4	33.6	31.0	38.2	17.0	31.0	25.6	30.4	28.8	29.7	44.6	27.4	28.1	8.6	33.8	20.2	19.8	26.5	12.9	41.2	55.7	11.6	23.5	50.3	12.6	19.0	30.6	26.2	27.2	15.2	17.2	15.2	25.7	24.0	29.8	42.2	29.7	25.1	19.9	49.7	14.8	23.6	25.0	6.2	1.1	1.0	1.3	0.6	1.6	1.1	1.5	1.5	0.7	2.8	1.4	0.9	1.2	1.1	2.8	0.7	0.9	1.0	11.5	13.8	8.0	12.2	11.9	11.4	10.1	11.0	8.1	8.8	12.2	8.4	13.0	16.0	12.4	160.9	14.2	16.6	8.6	9.3	19.9	10.9	11.9	7.6	12.8	14.3	15.2	20.2	4.2	8.2	5.7	13.5	13.7	18.2	5.5	7.1	23.6	13.8	23.4	12.2	126.1	11.5	9.3	16.9	11.2	8.0	19.0	74.2	18.2	28.9	37.7	8.4	130.1	12.5	18.3	12.8	13.5	3.8	6.8	15.3	12.4	53.4	8.2	28.8	5.2	95.0	54.5	11.3	7.7	20.3	24.0	7.3	17.6	18.3	11.2	17.7	0.0	21.1	16.8	10.1	15.0	12.8	15.8	4.4	12.9	77.4	13.5	7.1
HS6ST1	HS6ST	ENSG00000136720	"Heparan sulfate 6-O-sulfotransferase 1"	O60243	2	128236716-128318868	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 75.4;Granulosa cells: 285.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"EFO-21: 131.2;HMC-1: 206.6;SCLC-21H: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044586			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA		72000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA044586: AB_10963057"	"unprognostic (9.94e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.94e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	16.2	63.4	36.2	8.8	33.8	5.1	16.1	24.4	45.5	15.5	10.9	15.4	8.7	12.3	6.1	34.1	17.5	21.0	19.0	35.4	26.5	71.4	46.8	17.0	8.4	32.1	34.7	26.4	30.8	8.8	15.2	12.0	33.6	28.2	6.9	26.4	26.0	22.8	36.2	26.5	15.1	6.4	31.2	32.1	12.7	25.0	39.9	14.5	14.2	18.7	7.4	19.4	23.1	28.9	12.5	17.4	46.0	26.5	17.5	32.5	24.7	15.1	19.1	14.8	8.1	9.0	8.0	11.9	131.2	19.4	6.9	32.5	17.5	29.1	5.5	19.9	18.1	10.5	6.4	87.9	21.1	18.4	206.6	43.9	33.9	11.9	3.6	4.9	8.0	31.8	6.7	12.1	5.4	25.7	49.6	81.0	55.3	4.7	10.7	16.1	12.6	61.9	13.4	36.3	112.9	28.4	12.1	30.1	6.7	30.6	12.2	6.9	9.6	13.1	28.9	49.1	12.3	7.2	7.6	2.7	7.9	13.0	9.7	3.0	0.7	0.6	1.0	0.4	0.1	0.7	0.4	0.6	0.5	0.7	0.4	0.4	0.2	0.2	1.5	2.3	0.2	0.6	36.2	33.8	24.4	45.5	35.4	26.5	32.1	34.7	33.6	31.2	39.9	28.9	9.5	25.6	8.9	20.9	4.9	16.2	11.2	16.1	14.8	9.4	15.1	12.8	7.3	10.0	10.3	75.4	31.3	9.7	7.3	22.3	5.9	15.4	0.9	22.9	11.5	12.6	3.0	6.9	24.2	5.8	36.9	12.6	4.1	39.7	57.0	285.6	30.0	23.8	10.7	21.9	20.3	6.5	8.2	14.2	9.2	3.3	11.8	9.1	7.2	5.6	6.7	8.2	1.0	6.6	10.4	6.6	12.0	17.0	3.2	9.7	6.9	3.3	8.7	32.8	6.6	7.6	9.4	1.1	3.1	18.3	17.0	23.3	3.5	27.1	3.7	8.9
HS6ST2		ENSG00000171004	"Heparan sulfate 6-O-sulfotransferase 2"	Q96MM7	X	132626016-132961395	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;kidney: 13.9;ovary: 14.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.7;Excitatory neurons: 37.5;Inhibitory neurons: 44.2;Leydig cells: 62.7;Oligodendrocyte precursor cells: 54.3;Peritubular cells: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 46.2;HeLa: 28.1;RH-30: 66.1;RT4: 33.7;SH-SY5Y: 82.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034625	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA034625: AB_10612119"	"unprognostic (7.62e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.39e-5)"	"unprognostic (1.36e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.03e-4)"	0.2	2.4	12.4	0.6	10.0	0.0	2.0	1.2	7.4	1.0	0.0	0.6	0.1	3.5	2.4	3.9	1.8	0.3	0.2	9.6	10.7	13.9	0.0	0.7	0.1	6.3	22.5	14.1	5.3	0.3	1.1	8.4	7.3	2.8	0.8	1.5	0.9	0.8	6.2	0.2	0.1	1.5	4.9	0.0	0.9	2.9	20.3	0.6	0.4	0.9	0.5	2.5	0.7	2.6	10.7	0.1	14.5	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.0	0.0	0.0	15.2	0.0	0.0	0.5	21.7	0.1	0.0	0.0	46.2	0.1	28.1	0.0	0.0	0.0	0.0	0.7	20.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	7.8	0.3	0.1	11.8	7.2	0.6	0.0	66.1	0.0	13.3	33.7	1.8	82.0	14.8	0.0	0.1	23.7	0.0	0.1	0.0	0.0	2.6	9.6	23.8	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.4	10.0	1.2	7.4	9.6	10.7	6.3	22.5	7.3	4.9	20.3	2.6	0.0	0.0	0.0	1.6	0.0	0.3	0.2	1.8	6.8	0.2	4.3	2.4	0.8	0.0	5.5	3.7	0.0	35.7	0.2	0.3	5.9	0.0	0.5	0.3	0.6	0.5	0.0	0.0	37.5	2.0	2.6	2.6	0.0	0.1	0.0	0.1	0.0	0.0	3.4	0.0	44.2	0.2	2.0	0.0	0.0	1.1	62.7	0.2	0.0	10.3	0.0	5.3	0.0	54.3	1.4	0.8	0.2	35.3	0.0	1.3	0.0	0.1	9.8	0.4	0.0	17.9	0.3	0.3	1.1	11.1	0.3	17.4	0.1	0.3	0.2	1.8
HS6ST3		ENSG00000185352	"Heparan sulfate 6-O-sulfotransferase 3"	Q8IZP7	13	96090107-96839562	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 12.5"	"Group enriched"	"Detected in some"	27	"Excitatory neurons: 1308.8;Inhibitory neurons: 893.1;Oligodendrocyte precursor cells: 968.6"	"Cancer enhanced"	"Detected in many"		"breast cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"RT4: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA078257			Approved	"Nucleoplasm,Nuclear membrane,Plasma membrane,Actin filaments"	"Intracellular and membrane"	NA	NA		24000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA078257: AB_2732374"	"unprognostic (2.34e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.78e-2)"		"unprognostic (1.55e-1)"		"unprognostic (3.67e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (6.12e-5)"	"unprognostic (1.54e-4)"	"unprognostic (2.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.89e-2)"	1.4	4.2	1.4	0.2	3.5	0.0	0.3	0.0	9.0	1.8	0.0	0.2	0.4	2.1	2.1	0.4	0.5	0.2	0.9	12.5	7.3	0.8	0.0	0.0	0.0	0.1	5.2	0.1	2.2	2.1	1.9	0.0	0.3	0.2	0.1	2.2	0.0	0.2	1.1	0.5	0.4	1.5	0.3	0.0	0.9	0.3	6.1	0.0	2.4	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	17.3	0.9	0.7	0.1	0.1	0.0	0.2	0.5	0.0	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.5	0.0	9.0	12.5	7.3	0.1	5.2	0.3	0.3	6.1	0.0	0.0	0.0	0.0	33.6	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	0.6	0.1	0.0	0.0	1308.8	0.6	0.1	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	3.3	893.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	38.4	0.0	0.9	0.0	968.6	16.5	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	1.8	0.1	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928790	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.7;placenta: 110.9"	"Cell type enriched"	"Detected in many"	11	"monocytes: 2612.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	14	"eosinophil: 465.0"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 465.0"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 61.8"	"Region enriched"	"Detected in many"	12	"basal ganglia: 34.1"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	9.8	0.7	0.6	40.5	0.4	0.7	2.0	0.4	0.8	7.2	1.0	5.3	10.3	10.2	1.2	1.3	2.6	6.2	1.8	0.4	0.6	1.7	2.4	25.9	58.7	0.7	0.3	1.2	1.2	0.2	0.1	110.9	0.5	2.0	8.2	1.3	1.9	3.0	8.1	1.3	8.4	2.4	0.4	23.0	5.8	1.1	0.8	31.2	4.0	0.6	31.5	9.1	0.5	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.9	7.6	4.8	0.3	0.8	0.0	61.8	0.0	3.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	8.4	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	9.1	0.2	0.2	0.0	0.3	0.0	32.5	1.3	465.0	0.1	1.4	0.1	0.2	0.1	0.0	26.4	0.3	0.1	0.2	4.9	0.1	0.1	0.3	0.1	1.2	0.6	0.4	0.4	0.8	0.4	0.6	0.7	0.3	0.5	0.4	0.8	0.6	24.9	0.0	0.5	0.7	4.4	0.4	0.2	18.3	0.0	0.0	0.5	0.1	0.3	0.0	76.0	0.0	0.0	0.0	0.3	8.3	0.0	4.4	3.7	70.1	23.0	6.9	0.0	0.0	0.2	8.1	0.0	0.3	0.0	223.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	2.0	3.7	28.1	1.8	0.0	13.6	0.0	0.0	2612.3	3.0	0.0	0.0	0.1	0.4	0.0	0.4	2.4	0.5	0.0	0.0	33.3	0.2	0.0	1.2	8.4	0.0	0.1	0.1	0.6	0.0	1.3	0.0	1.3	2.0
IDO2	INDOL1	ENSG00000188676	"Indoleamine 2,3-dioxygenase 2"	Q6ZQW0	8	39934614-40016391	"Metabolic proteins, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"liver: 5.4;placenta: 4.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 21.0;Endometrial ciliated cells: 18.4;Glandular and luminal cells: 51.3;Late spermatids: 6.9;monocytes: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA054911			Approved	Cytosol		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"		"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA054911: "	"unprognostic (2.00e-3)"	"unprognostic (2.34e-5)"	"unprognostic (2.22e-3)"	"unprognostic (4.41e-3)"	"unprognostic (5.37e-2)"	"unprognostic (3.69e-5)"	"unprognostic (1.19e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.78e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.25e-1)"	"unprognostic (6.47e-7)"	"unprognostic (3.25e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.08e-3)"	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.9	0.1	21.0	18.4	4.4	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	51.3	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.0	0.0	0.0	1.9	6.9	0.3	0.8	0.0	0.0	14.6	0.0	0.0	0.5	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.1
INMT		ENSG00000241644	"Indolethylamine N-methyltransferase"	O95050	7	30697985-30757602	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	Detoxification	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 205.8"	"Group enriched"	"Detected in many"	7	"Endothelial cells: 150.4;Hepatic stellate cells: 268.4;Leydig cells: 285.2;Peritubular cells: 455.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 22.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CACO-2: 16.7;HHSteC: 6.7"									HPA061343			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles"		"HPA061343: AB_2684483"	"unprognostic (1.70e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.26e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-4)"	"prognostic favorable (5.72e-4)"	"unprognostic (3.08e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.58e-2)"	64.5	51.2	3.1	2.7	6.0	0.7	10.2	7.9	13.1	6.4	9.3	9.5	2.8	16.0	25.4	15.0	43.8	8.3	75.6	7.6	8.7	20.0	23.3	205.8	7.6	9.6	6.0	17.7	11.3	5.7	7.8	33.7	5.6	29.6	4.6	0.5	9.1	48.0	14.4	4.2	8.5	25.7	2.5	13.0	12.7	15.8	4.8	1.7	21.3	13.2	4.0	11.1	7.2	16.6	0.0	0.1	0.0	0.1	1.5	2.1	0.3	0.2	2.1	0.0	0.0	16.7	0.1	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	6.7	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.2	0.1	0.0	0.4	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.5	0.1	0.6	0.0	0.6	0.1	0.0	1.0	0.0	0.6	0.2	0.0	0.7	0.3	0.0	0.2	0.1	0.3	1.6	0.2	0.2	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.4	0.2	0.2	0.8	0.5	0.1	0.3	0.1	0.2	3.1	6.0	7.9	13.1	7.6	8.7	9.6	6.0	5.6	2.5	4.8	16.6	39.4	0.0	3.6	0.0	1.0	2.2	0.1	0.0	1.2	0.0	0.4	0.6	10.0	7.2	2.5	0.0	0.0	0.7	0.3	0.0	0.0	0.0	2.3	0.1	0.8	150.4	1.2	8.0	0.0	0.0	0.4	38.2	0.0	0.0	0.0	0.9	268.4	5.1	0.8	0.0	0.0	0.2	0.0	16.6	4.4	16.0	285.2	0.7	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	455.5	1.5	0.2	0.0	0.1	0.7	0.0	32.9	5.0	19.6	1.3	1.3	0.4	2.3	1.8	1.3	0.2	0.0	0.4
LRTOMT	"CFAP111, COMT2, DFNB63, LRRC51, LRTOMT1, LRTOMT2"	ENSG00000184154	"Leucine rich transmembrane and O-methyltransferase domain containing"	Q96E66	11	72080337-72096895	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 67.1;testis: 49.3"	"Group enriched"	"Detected in many"	12	"Early spermatids: 574.9;Late spermatids: 2222.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 39.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039949	Approved		Uncertain	Microtubules		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules		"HPA039949: AB_10960708"	"unprognostic (2.68e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (8.09e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.22e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (6.12e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	5.0	4.5	21.1	2.5	21.8	2.1	8.7	19.5	24.2	8.7	25.1	5.4	3.7	7.2	17.1	3.8	67.1	3.4	3.7	19.1	19.2	11.7	7.9	7.7	3.2	23.0	25.7	8.1	8.9	10.3	8.9	5.4	21.4	9.3	7.7	19.7	4.4	5.4	7.5	5.8	3.4	5.7	23.4	4.0	5.5	49.3	21.0	4.5	11.0	4.6	3.6	4.1	3.8	22.0	3.9	13.7	8.9	6.9	7.3	6.7	2.1	4.4	3.6	4.0	3.5	6.6	20.4	5.1	6.6	7.8	9.6	7.3	6.3	10.8	4.5	9.4	6.2	3.5	6.3	4.8	1.3	3.0	3.9	2.9	5.4	6.0	4.6	6.4	1.5	10.2	4.0	7.8	6.0	13.6	9.0	6.0	4.4	22.8	3.6	10.8	8.6	7.7	15.9	4.7	8.2	6.2	8.7	19.4	10.4	6.1	39.6	3.3	6.5	4.0	5.7	11.3	3.1	8.0	9.4	5.8	4.0	2.5	4.5	1.8	1.7	3.5	2.0	1.9	1.9	3.2	2.1	1.6	1.0	3.5	1.8	1.8	6.1	6.6	1.3	2.8	4.6	1.4	21.1	21.8	19.5	24.2	19.1	19.2	23.0	25.7	21.4	23.4	21.0	22.0	4.6	0.0	1.5	3.3	2.5	2.3	7.5	10.0	1.8	3.5	8.4	7.5	2.2	5.7	10.7	3.7	12.5	12.7	1.4	4.4	11.7	7.5	574.9	84.3	3.0	6.5	1.2	3.6	2.0	2.5	7.7	5.3	4.1	7.2	0.0	2.2	3.6	6.0	3.1	6.7	1.9	10.8	10.2	1.6	2.8	2222.2	14.9	3.3	1.8	1.9	1.4	21.3	4.1	2.0	3.6	2.0	2.5	10.1	5.1	6.8	4.0	19.9	113.1	16.6	6.6	6.1	7.9	90.3	28.1	2.2	2.4	13.1	1.7	2.9	3.4	6.5
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 230.3"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 819.8;Proximal tubular cells: 569.9;Undifferentiated cells: 285.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 162.1;HHSteC: 302.9;HSkMC: 76.1;hTCEpi: 87.2;RT4: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Supported	Mitochondria,Cytosol		No	No				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	143.9	27.7	24.7	8.6	27.6	0.4	71.6	26.5	26.6	26.6	13.9	116.4	163.4	24.0	14.1	46.7	39.1	16.9	49.6	22.3	31.7	76.9	119.1	63.5	2.4	26.9	32.5	40.7	39.1	31.4	4.0	30.2	56.4	46.3	117.9	28.2	77.3	35.0	33.5	37.4	230.3	24.0	21.3	6.3	55.9	3.7	41.4	9.9	118.4	34.3	5.3	65.0	38.8	19.0	0.0	3.7	0.6	9.9	162.1	0.0	0.6	0.2	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	4.6	17.2	6.1	22.3	0.1	0.0	2.5	6.9	0.5	18.6	302.9	0.0	16.9	76.1	87.2	0.2	45.2	0.1	20.0	0.0	0.3	0.4	5.7	2.9	0.1	0.8	1.6	20.7	5.0	0.0	0.3	0.5	22.3	131.8	3.1	7.8	0.0	0.0	0.3	0.4	0.5	0.0	8.7	0.0	8.2	0.7	0.0	0.3	0.0	0.0	9.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	27.6	26.5	26.6	22.3	31.7	26.9	32.5	56.4	21.3	41.4	19.0	35.2	70.5	146.9	23.2	4.6	11.0	177.7	32.3	116.7	5.0	13.6	10.2	101.3	94.4	49.3	60.7	22.9	11.5	0.2	248.0	121.3	36.7	25.2	50.4	42.5	43.6	38.0	4.8	4.0	13.4	21.3	24.3	40.2	175.1	5.7	7.3	53.6	193.7	6.6	3.3	5.0	137.5	67.1	12.2	2.1	33.9	5.6	6.7	10.6	21.5	17.1	25.4	0.0	7.5	1.3	49.5	140.5	0.0	2.6	64.6	819.8	569.9	32.8	27.4	6.6	4.4	30.5	1.3	0.8	120.6	14.3	207.0	3.7	3.5	285.1	129.0
MAOB		ENSG00000069535	"Monoamine oxidase B"	P27338	X	43766610-43882450	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 317.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 120.6;granulocytes: 137.8;Hepatocytes: 221.1;Peritubular cells: 95.2;Proximal enterocytes: 178.8;Proximal tubular cells: 182.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Hep G2: 41.4;SiHa: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002328, CAB037200"	Enhanced					NA	NA		110000		"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB037200: AB_1841012, HPA002328: AB_1854062"	"unprognostic (1.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.74e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.90e-3)"	78.0	51.1	99.3	6.5	102.8	0.1	45.7	89.1	117.7	32.3	83.5	46.5	73.5	119.4	55.0	31.4	98.0	17.3	97.8	93.9	149.1	124.2	317.6	33.0	6.1	143.8	134.2	155.4	10.9	15.6	25.9	11.2	125.9	82.9	16.5	13.9	78.5	155.5	114.6	9.9	79.0	103.3	115.8	2.4	23.7	9.0	145.2	3.8	5.6	65.1	7.1	28.3	25.4	115.8	0.0	1.0	0.1	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	5.4	4.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	8.1	41.4	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.3	3.5	0.0	0.0	0.0	0.0	0.4	4.0	0.0	0.1	1.1	78.2	0.0	0.5	0.6	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	99.3	102.8	89.1	117.7	93.9	149.1	143.8	134.2	125.9	115.8	145.2	115.8	5.9	0.0	4.1	53.5	0.4	5.5	0.4	1.2	1.8	1.4	3.5	22.4	120.6	52.9	1.9	5.5	4.2	0.4	0.0	10.2	62.6	20.1	0.4	26.4	81.6	10.3	0.0	2.7	36.9	2.8	0.5	17.0	16.3	6.0	137.8	69.6	7.5	221.1	1.5	15.2	7.6	6.4	12.2	4.3	3.6	2.1	46.0	1.8	7.2	9.4	0.0	27.2	0.0	11.6	1.3	7.9	7.8	95.2	0.3	0.6	178.8	182.6	11.8	1.0	13.1	2.6	18.4	0.3	0.4	2.3	4.0	0.4	5.5	0.5	10.5	0.5
NDST1	"HSST, NST1"	ENSG00000070614	"N-deacetylase and N-sulfotransferase 1"	P52848	5	150485818-150558211	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	"Hydrolase, Multifunctional enzyme, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 1.4;classical monocyte: 5.5;eosinophil: 3.6;intermediate monocyte: 1.7;myeloid DC: 4.2;neutrophil: 5.4;non-classical monocyte: 4.7"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.2;granulocytes: 5.4;monocytes: 5.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060532	Approved					NA	NA		1400000	"Cluster 14: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA060532: AB_2684310"	"unprognostic (1.36e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.77e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (4.97e-3)"	"unprognostic (6.92e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.08e-2)"	37.2	22.7	39.4	14.0	45.1	7.6	28.6	43.8	38.9	16.0	3.9	17.6	12.5	17.3	7.9	38.8	14.7	15.2	26.8	30.8	30.7	15.4	42.6	34.3	7.3	62.6	48.8	23.0	39.7	20.5	6.7	12.2	50.3	14.5	9.5	13.9	37.4	16.8	23.6	34.2	17.4	19.2	47.8	43.4	16.0	14.5	51.5	4.2	22.9	13.0	9.9	14.1	18.7	60.0	32.4	28.3	46.1	56.4	45.3	44.9	46.3	58.1	75.9	56.8	84.8	84.1	33.3	22.0	57.6	116.8	91.0	54.4	25.1	118.0	37.6	2.6	38.9	26.0	18.5	13.2	33.5	19.5	45.5	61.6	48.1	68.7	31.0	56.9	78.3	12.9	25.3	7.8	56.3	27.5	2.3	6.2	21.6	9.1	33.0	37.6	38.4	9.8	33.4	32.5	13.8	48.3	35.2	108.5	46.3	32.7	58.3	4.8	38.8	96.4	86.2	42.3	48.3	17.1	4.7	8.1	79.2	30.1	38.0	1.4	5.5	3.6	0.1	1.7	0.0	0.4	0.0	0.4	4.2	0.1	0.0	0.2	5.4	0.0	4.7	0.3	0.0	2.8	39.4	45.1	43.8	38.9	30.8	30.7	62.6	48.8	50.3	47.8	51.5	60.0	29.8	38.5	8.7	23.8	1.9	5.7	3.5	14.4	6.2	11.6	29.9	15.4	11.5	17.2	9.6	16.5	8.4	8.6	0.5	20.9	1.9	10.4	0.7	5.5	7.7	35.5	1.2	3.2	12.0	10.5	11.3	11.0	2.0	6.8	1.3	20.4	31.8	47.5	7.7	13.5	11.7	5.3	8.2	14.4	7.6	1.9	12.5	8.7	10.6	16.9	7.4	12.1	0.0	12.1	39.7	18.8	6.6	32.0	3.7	7.9	17.8	8.8	3.8	11.3	0.0	8.7	11.5	0.7	1.6	17.4	12.4	4.5	1.2	11.8	5.8	5.3
NDST2	"HSST2, NST2"	ENSG00000166507	"N-deacetylase and N-sulfotransferase 2"	P52849	10	73801911-73811798	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 13.7;granulocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 110.2"									HPA051515	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 32: T-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA051515: AB_2681517"	"unprognostic (8.84e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.43e-3)"	"unprognostic (5.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (4.08e-7)"	"unprognostic (3.71e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (9.06e-2)"	14.9	16.7	11.6	19.6	11.6	53.6	13.3	15.7	14.2	15.7	10.6	13.6	10.7	15.7	11.6	16.8	15.0	15.1	11.4	11.6	11.7	14.4	10.9	17.0	24.6	12.6	11.4	15.8	14.1	18.4	15.8	12.5	11.2	15.6	12.1	14.9	17.7	14.2	8.9	18.8	17.4	15.8	10.4	35.3	13.6	13.6	12.5	31.9	13.3	8.5	23.9	15.3	15.4	11.5	10.0	7.9	16.7	26.2	20.9	23.0	9.1	12.3	24.5	13.4	13.3	4.6	12.4	9.5	7.1	21.8	13.6	11.6	8.1	11.8	9.6	23.4	8.5	9.3	7.0	7.3	36.7	11.8	110.2	22.9	14.5	21.4	22.4	41.1	17.5	17.9	9.2	33.8	16.6	8.1	12.7	13.4	4.5	6.4	36.4	8.5	8.2	5.9	11.5	7.2	5.5	9.0	9.9	23.5	7.5	11.3	18.6	18.6	29.5	6.3	7.8	9.1	8.4	17.4	8.0	11.8	7.2	17.0	5.5	0.7	2.7	1.1	2.7	1.9	3.1	1.2	2.3	2.3	2.0	1.3	2.6	3.4	2.8	1.1	1.7	3.4	1.6	1.8	11.6	11.6	15.7	14.2	11.6	11.7	12.6	11.4	11.2	10.4	12.5	11.5	1.5	0.0	3.0	13.7	5.4	1.3	0.8	0.6	1.2	0.7	4.1	2.3	1.8	0.0	1.8	0.0	0.0	1.4	3.6	4.7	0.0	5.4	7.5	0.8	1.2	1.1	2.4	7.8	7.5	9.6	1.5	1.9	4.6	0.7	14.5	0.3	1.4	4.2	5.2	1.7	7.6	2.6	2.0	8.5	3.1	10.4	0.0	10.8	1.8	2.8	5.4	0.8	0.0	5.0	5.0	7.0	3.2	0.0	10.6	1.3	2.4	7.4	2.7	0.8	0.0	1.4	1.5	2.3	1.7	4.7	1.6	6.2	5.3	0.3	2.2	1.9
NDST3	HSST3	ENSG00000164100	"N-deacetylase and N-sulfotransferase 3"	O95803	4	118033618-118258634	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"brain: 4.8;liver: 1.3;lymphoid tissue: 2.9;retina: 2.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 299.6;Inhibitory neurons: 128.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"MOLT-4: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056189	Uncertain					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA056189: AB_2683061"	"unprognostic (1.95e-2)"	"unprognostic (7.58e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.55e-7)"	"unprognostic (4.05e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.37e-1)"	"unprognostic (4.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (8.85e-2)"	0.0	0.5	1.2	0.0	4.8	0.0	0.0	3.3	2.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	1.0	0.1	1.3	0.0	0.1	0.6	0.8	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.4	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.8	3.3	2.8	1.5	1.0	0.6	0.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	20.7	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	299.6	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.4	0.6	0.1	6.7	128.6	0.2	0.0	42.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.3	0.0	12.1	18.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1
NDST4		ENSG00000138653	"N-deacetylase and N-sulfotransferase 4"	Q9H3R1	4	114827763-115113876	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 9.0"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 29.3;Oligodendrocyte precursor cells: 15.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"hypothalamus: 2.3;medulla oblongata: 8.3;midbrain: 3.5;pons: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.9;CACO-2: 3.7;RH-30: 14.5;T-47d: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA011129	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA011129: AB_1079460"	"unprognostic (5.58e-2)"				"unprognostic (5.90e-2)"					"unprognostic (4.82e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.08e-1)"		"unprognostic (1.11e-1)"	"unprognostic (1.94e-1)"		"unprognostic (6.55e-2)"	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.6	2.3	0.0	0.0	0.0	0.0	8.3	3.5	1.5	0.0	0.0	0.0	0.0	9.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.7	0.3	0.2	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.2	0.6	2.3	8.3	3.5	9.0	0.6	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	29.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	15.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0
SULT1A3	"STM, TL-PST"	ENSG00000261052	"Sulfotransferase family 1A member 3"	P0DMM9	16	30199228-30204310	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Catecholamine metabolism, Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 237.2"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 129.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 61.3;intermediate monocyte: 53.2;myeloid DC: 33.7;non-classical monocyte: 25.0"	"Group enriched"	"Detected in all"	11	"dendritic cells: 33.7;monocytes: 61.3"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 166.9;Hep G2: 303.6;Karpas-707: 239.4"									"HPA049500, HPA051051"	Supported					NA	NA		160000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.61e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.18e-8)"	"unprognostic (2.34e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.48e-5)"	15.7	13.7	53.3	21.9	54.0	36.8	15.7	56.3	72.9	15.4	54.3	57.3	237.2	16.8	18.0	14.3	18.0	14.8	11.0	54.0	53.9	34.6	34.5	26.6	30.3	53.8	53.0	10.8	15.9	17.5	23.8	22.4	54.3	20.1	46.4	23.2	25.8	17.8	11.0	25.7	146.6	24.5	52.0	31.8	22.2	9.6	54.3	16.3	20.2	18.9	29.3	13.5	10.5	55.9	32.6	48.8	30.6	21.3	28.4	19.8	46.0	15.8	16.9	16.7	18.9	21.1	166.9	16.9	150.0	16.0	10.9	45.5	38.8	14.0	16.7	19.9	30.6	93.2	61.2	303.6	11.1	14.2	34.9	21.9	20.9	25.4	5.9	34.2	30.6	21.9	19.0	239.4	12.0	55.4	9.6	62.3	19.1	76.2	20.9	38.6	14.8	32.2	29.4	22.0	15.3	24.7	4.8	43.0	7.8	11.4	23.8	22.1	38.3	34.0	17.4	29.4	11.7	28.8	78.1	8.7	17.4	31.7	20.5	1.9	61.3	0.3	4.3	53.2	0.9	3.4	1.1	1.5	33.7	1.7	0.8	0.7	1.6	1.4	25.0	0.5	0.9	20.4	53.3	54.0	56.3	72.9	54.0	53.9	53.8	53.0	54.3	52.0	54.3	55.9	3.3	12.8	12.0	0.0	4.2	2.0	2.2	1.2	0.6	5.3	2.4	1.3	1.8	4.3	7.6	0.0	8.4	5.3	2.8	13.9	0.0	3.3	1.3	0.9	0.9	5.8	1.2	6.1	0.0	4.0	2.3	4.4	2.6	1.3	1.3	1.7	3.9	2.8	1.5	1.7	0.0	13.4	2.0	5.0	3.7	0.5	0.9	2.6	1.8	0.0	4.9	2.6	4.1	0.0	0.0	6.3	25.3	1.9	1.4	4.3	129.1	0.5	2.3	6.7	0.0	1.7	1.7	0.8	0.3	0.9	2.7	3.0	3.8	1.2	26.8	2.1
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721167-69787961	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 99.4;stomach 1: 44.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 298.2;Gastric mucus-secreting cells: 61.7;Paneth cells: 153.4;Proximal enterocytes: 234.3;Undifferentiated cells: 76.4"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 10.7;neutrophil: 32.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 32.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 110.9;OE19: 26.3;TIME: 36.2;U-2197: 31.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	3.0	0.7	2.3	10.7	4.3	5.5	2.1	8.0	6.8	1.5	2.5	69.9	99.4	2.0	2.4	2.0	1.5	1.5	1.9	3.2	1.8	1.9	23.8	2.5	4.2	0.9	0.9	3.0	0.8	0.9	0.1	1.3	2.0	2.5	62.2	3.9	0.8	1.4	1.2	1.3	95.3	5.1	0.3	9.7	44.9	1.2	2.0	3.0	2.7	2.3	7.5	1.6	0.9	5.6	0.7	0.6	0.8	0.8	1.8	1.9	1.2	0.8	0.4	0.3	0.3	0.7	0.7	1.3	0.7	0.8	1.0	1.1	0.1	0.2	0.7	1.5	1.0	1.0	1.2	0.5	2.7	1.3	1.3	12.3	0.2	0.3	0.5	1.1	110.9	1.6	0.6	2.5	1.0	0.7	0.6	1.0	0.8	26.3	0.4	0.6	3.7	0.8	0.2	1.8	1.3	0.8	0.5	0.3	0.5	0.7	1.6	0.6	36.2	1.0	1.7	31.5	0.6	1.9	1.0	0.6	0.4	3.3	1.3	10.7	4.8	1.4	1.0	2.7	0.3	0.1	1.5	0.4	2.7	0.2	4.9	2.5	32.0	2.9	3.4	0.2	0.9	2.6	2.3	4.3	8.0	6.8	3.2	1.8	0.9	0.9	2.0	0.3	2.0	5.6	1.3	19.2	20.8	0.3	0.9	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	8.4	0.0	0.0	0.0	4.9	298.2	0.0	0.3	0.1	1.2	0.1	2.2	33.7	2.7	0.1	4.4	0.2	1.8	61.7	0.2	16.4	0.2	2.9	45.1	0.3	0.0	0.1	42.6	0.0	24.9	1.8	0.0	0.0	9.4	0.0	3.7	15.4	0.0	11.3	0.0	0.1	18.2	153.4	0.0	1.0	0.2	234.3	1.5	12.8	0.0	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.3	6.7	0.1	76.4	0.1
SULT1C2	"ST1C1, SULT1C1"	ENSG00000198203	"Sulfotransferase family 1C member 2"	O00338	2	108288639-108309915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 70.3;stomach 1: 163.3"	"Cell type enriched"	"Detected in many"	7	"Gastric mucus-secreting cells: 553.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RPTEC TERT1: 25.4;RT4: 7.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007190	Approved					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA007190: AB_1857647"	"unprognostic (3.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.63e-2)"	"unprognostic (9.96e-5)"	0.7	0.0	0.2	0.6	0.2	0.0	0.9	0.2	0.6	2.4	7.5	2.5	29.2	0.5	15.9	0.3	2.0	6.2	1.1	0.5	0.2	70.3	2.8	2.2	1.8	0.3	0.4	0.2	5.3	5.9	2.9	1.3	0.6	0.5	5.2	0.0	1.4	0.9	0.6	0.1	3.3	0.8	0.2	0.5	163.3	0.1	0.7	0.4	19.4	0.6	0.8	0.7	0.5	1.2	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.8	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.2	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.3	0.0	25.4	7.3	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.5	0.2	0.3	0.4	0.6	0.2	0.7	1.2	7.0	3.2	14.1	0.3	1.0	1.5	1.6	0.0	0.0	0.9	0.3	0.1	2.2	15.7	3.1	20.2	2.1	0.3	0.0	3.9	58.7	7.6	0.1	5.7	0.8	4.8	0.0	0.0	0.4	0.2	0.3	2.6	553.0	5.6	1.3	0.2	3.3	0.9	18.6	1.7	0.2	6.4	12.2	0.3	5.4	0.2	0.0	2.7	0.0	3.7	0.1	0.1	0.0	0.0	0.1	6.2	6.8	0.0	2.0	2.8	9.6	73.4	1.0	1.5	0.0	2.9	1.2	0.7	0.3	0.0	1.8	0.1	1.1	0.1	4.9	1.3
SULT1C4	"SULT1C, SULT1C2"	ENSG00000198075	"Sulfotransferase family 1C member 4"	O75897	2	108377911-108388989	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 13.3;Cholangiocytes: 37.1;Endothelial cells: 13.2;Granulosa cells: 15.3;Hepatic stellate cells: 17.9;Muller glia cells: 12.3;Oligodendrocyte precursor cells: 17.6"	"Group enriched"	"Detected in many"	6	"glioma: 7.1;renal cancer: 20.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.5;HUVEC TERT2: 10.7;SH-SY5Y: 42.0;SuSa: 11.6"					"Low region specificity"	"Detected in many"			HPA034530			Approved	Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA034530: AB_10670170"	"unprognostic (2.47e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.35e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-3)"	"prognostic favorable (9.99e-7)"	"unprognostic (1.79e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.38e-1)"	6.2	2.0	15.5	1.1	16.1	0.5	5.2	16.9	17.2	21.9	12.9	3.4	1.5	11.1	8.0	2.3	9.3	27.1	10.9	13.6	18.9	18.2	3.7	10.3	1.8	18.8	27.3	27.9	2.9	1.0	5.2	13.0	20.4	6.6	2.2	8.6	1.6	8.9	3.1	0.7	3.2	5.5	18.1	1.4	2.0	1.4	19.0	5.0	4.5	6.2	1.3	3.8	5.3	15.8	0.0	0.1	9.5	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.1	0.0	1.2	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	42.0	0.0	0.0	0.0	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	15.5	16.1	16.9	17.2	13.6	18.9	18.8	27.3	20.4	18.1	19.0	15.8	13.3	0.0	0.5	10.4	0.0	0.3	0.7	0.0	0.0	2.0	0.4	0.3	0.7	37.1	0.0	9.2	0.0	0.3	0.0	0.0	0.0	0.3	5.9	10.9	3.1	13.2	0.0	2.7	0.6	0.2	0.1	4.9	0.0	3.8	0.0	15.3	17.9	0.0	0.9	1.7	0.5	0.0	0.0	1.3	1.0	1.1	1.5	0.4	0.0	7.5	0.1	12.3	0.0	17.6	0.4	0.1	0.0	4.5	1.4	0.7	0.0	7.7	0.0	1.0	0.0	1.4	1.8	0.6	0.7	0.0	0.4	0.3	0.2	7.2	0.0	0.2
SULT4A1	"hBR-STL-1, SULTX3"	ENSG00000130540	"Sulfotransferase family 4A member 1"	Q9BR01	22	43824509-43862513	"Metabolic proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"brain: 90.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 23.0;Early spermatids: 23.7;Excitatory neurons: 53.1;Horizontal cells: 23.5;Inhibitory neurons: 55.2;Late spermatids: 29.4;Rod photoreceptor cells: 19.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 90.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003129	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA003129: AB_1080130"	"unprognostic (2.61e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.48e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.10e-2)"	"unprognostic (7.59e-4)"	"unprognostic (7.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.20e-3)"	"unprognostic (8.34e-3)"	0.0	2.7	22.3	0.3	23.2	0.0	0.0	1.6	90.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	22.2	21.7	0.1	0.0	0.0	0.0	9.6	0.0	0.0	0.2	0.0	2.5	0.0	8.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.4	0.8	5.9	0.0	0.0	0.0	0.0	0.0	0.3	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	23.2	1.6	90.2	22.2	21.7	9.6	0.0	8.0	0.0	5.9	25.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.3	0.0	23.0	0.2	0.5	1.4	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	23.7	1.1	1.3	0.4	0.0	0.0	53.1	0.0	0.0	0.4	0.0	3.7	0.0	1.9	0.0	0.0	0.1	23.5	55.2	0.0	0.0	0.0	0.0	29.4	0.0	0.1	0.0	10.3	0.0	4.0	0.0	8.0	6.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	19.5	0.0	0.0	0.2	3.0	5.7	0.0	0.0	0.0	0.0	3.2	0.0	0.0
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.0;intestine: 19.3;stomach 1: 15.0"	"Cell type enriched"	"Detected in many"	30	"Enteroendocrine cells: 1466.7"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Group enriched"	"Detected in some"	5	"hypothalamus: 3.4;midbrain: 9.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.5"	"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Uncertain		Uncertain	Cytosol		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.6	0.1	0.2	1.2	0.3	1.1	1.3	0.3	0.3	0.6	4.7	9.0	10.2	0.9	0.9	0.2	0.9	0.1	0.3	0.4	3.4	0.5	0.2	0.8	0.5	0.2	9.0	0.7	0.5	0.1	3.0	0.2	1.1	1.4	19.3	1.8	0.5	0.1	0.4	1.4	11.2	0.2	0.2	0.7	15.0	0.9	0.4	0.3	0.5	0.1	0.7	0.4	0.4	0.3	0.1	0.0	0.5	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.6	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.5	0.2	0.4	1.0	0.7	0.3	1.1	0.0	1.5	0.3	0.0	0.6	0.0	0.2	0.1	0.2	0.8	0.3	0.2	0.0	0.1	0.3	0.2	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.1	0.4	0.1	0.5	0.0	0.1	0.3	0.0	0.3	0.4	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.3	0.4	3.4	0.2	9.0	1.1	0.2	0.4	0.3	1.4	0.0	0.0	1.0	1.1	0.4	0.4	0.5	0.0	14.9	1.9	1.0	0.8	0.0	0.1	5.5	2.1	0.2	0.6	1.7	0.0	0.2	0.8	0.1	0.6	0.7	1466.7	0.4	0.5	0.6	0.0	1.2	2.0	0.2	0.0	5.6	0.4	0.2	0.2	1.7	0.4	48.2	0.0	0.3	1.4	0.8	0.9	0.5	0.0	0.0	0.1	1.4	1.0	0.0	0.6	0.4	13.4	1.2	0.3	2.3	1.5	0.3	0.9	5.6	6.6	1.3	1.3	2.8	3.7	0.0	1.4	0.0	1.2	0.0	2.7	0.4
TPH2	"FLJ37295, NTPH"	ENSG00000139287	"Tryptophan hydroxylase 2"	Q8IWU9	12	71938845-72186618	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Serotonin biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	716	"brain: 325.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.0;Inhibitory neurons: 3.2;Late spermatids: 7.4;Spermatogonia: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"midbrain: 325.8;pons: 141.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	31	"midbrain: 106.7;pons and medulla: 34.9"	"Group enriched"	"Detected in some"	5	"midbrain: 49.9;pons: 49.6"	CAB078198	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 34: Spermatids - Unknown function"			"CAB078198: AB_2665804"	"unprognostic (1.19e-1)"	"unprognostic (6.01e-1)"		"unprognostic (3.46e-2)"	"unprognostic (2.31e-1)"				"unprognostic (5.91e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.01e-2)"			"unprognostic (7.32e-2)"	"unprognostic (1.34e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	45.3	325.8	0.0	0.2	0.0	0.4	0.0	141.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	1.0	0.4	45.3	325.8	141.5	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.2	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1
UST	2OST	ENSG00000111962	"Uronyl 2-sulfotransferase"	Q9Y2C2	6	148747030-149076990	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 339.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032022	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA032022: AB_10603326"	"unprognostic (3.43e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.22e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.25e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.02e-2)"	6.0	12.2	6.3	3.0	7.4	0.2	6.2	10.0	7.9	7.6	7.5	9.2	1.7	6.8	5.6	4.6	9.2	6.0	4.3	5.8	16.0	3.6	1.3	5.2	3.9	28.2	17.2	11.6	13.1	4.6	1.9	4.6	14.1	6.3	2.7	6.8	3.2	4.8	1.7	6.7	5.7	8.8	13.5	6.5	5.0	6.7	22.7	6.5	27.5	5.8	3.7	8.8	7.7	15.6	0.1	3.2	18.2	14.0	21.5	17.8	0.1	7.9	20.5	3.8	9.8	0.0	1.2	6.7	1.7	12.3	9.5	5.7	13.0	6.6	7.6	9.1	9.9	0.2	10.0	0.1	7.9	0.3	2.8	9.2	14.6	9.8	18.1	7.6	0.2	11.1	0.0	0.0	3.0	8.3	0.1	0.0	10.7	32.4	4.2	3.3	2.5	7.7	0.1	14.8	9.4	0.0	26.4	6.3	5.0	13.0	4.7	0.3	0.4	10.9	1.3	2.5	7.4	0.0	0.0	0.0	12.1	5.4	6.3	0.0	0.0	0.0	0.6	0.2	0.4	0.3	0.4	0.5	0.4	0.5	0.0	0.2	0.0	2.5	0.3	0.4	0.1	0.1	6.3	7.4	10.0	7.9	5.8	16.0	28.2	17.2	14.1	13.5	22.7	15.6	0.9	3.2	3.2	70.2	4.5	9.4	5.4	2.6	3.4	0.1	1.7	1.5	1.7	0.0	2.7	1.8	0.0	2.0	8.9	0.2	0.0	0.1	1.1	0.3	8.7	0.6	0.0	0.0	36.3	2.0	0.3	16.3	7.1	0.4	0.0	12.3	1.4	0.3	1.7	0.0	39.7	1.8	10.2	1.0	20.9	3.4	18.3	2.8	5.4	80.6	1.0	14.6	5.2	339.8	3.2	1.1	0.3	11.3	0.4	5.9	0.0	0.6	2.3	0.8	0.0	6.8	3.5	2.9	5.7	1.9	11.6	1.4	2.0	10.2	0.5	6.8